0:[[["",{"children":[["locale","en","d"],{"children":["search",{"children":["(static)",{"children":[["slug","nanomedicine","d"],{"children":["__PAGE__",{}]}]}]}]}]},"$undefined","$undefined",true],"$L1",[[],["$L2",null]]]] 3:HL["/_next/static/css/f07341dcde9222bf.css",{"as":"style"}] 4:I{"id":"92264","chunks":["272:static/chunks/webpack-f66a319a14ac960a.js","744:static/chunks/7fd0f9f1-c04a42b14e6b17e7.js","55:static/chunks/55-fe44cf98282aae97.js"],"name":"","async":false} 5:I{"id":"59630","chunks":["272:static/chunks/webpack-f66a319a14ac960a.js","744:static/chunks/7fd0f9f1-c04a42b14e6b17e7.js","55:static/chunks/55-fe44cf98282aae97.js"],"name":"","async":false} 1:[["$","$L4",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","loading":"$undefined","loadingStyles":"$undefined","hasLoading":false,"template":["$","$L5",null,{}],"templateStyles":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","childProp":{"current":["$L6",null],"segment":["locale","en","d"]},"styles":[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/f07341dcde9222bf.css","precedence":"next"}]]}],null] 7:I{"id":"97562","chunks":["884:static/chunks/884-5f6867d114af7093.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","203:static/chunks/app/[locale]/layout-de056d243e0de07e.js"],"name":"","async":false} 8:I{"id":"77701","chunks":["884:static/chunks/884-5f6867d114af7093.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","203:static/chunks/app/[locale]/layout-de056d243e0de07e.js"],"name":"UrqlProvider","async":false} 9:I{"id":"16711","chunks":["884:static/chunks/884-5f6867d114af7093.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","203:static/chunks/app/[locale]/layout-de056d243e0de07e.js"],"name":"ThemeRegistry","async":false} a:I{"id":"87528","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"SearchHighlightContextProvider","async":false} d:I{"id":"7491","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"","async":false} 6:["$","html",null,{"lang":"en","children":["$","body",null,{"children":[["$","$L7",null,{"locale":"en","messages":{"searchResultCount":{"results":"{resultCount} companies for \"{ keyword }\"","loading":"Loading search results..."},"trendingProducts":{"service":"Service","product":"Product","by":"by","view":"View","verified":"Verified","topProducts":"Products and services for \"{ keyword }\"","loading":"Loading products..."},"filters":{"selectIndustries":"Select industry","selectLocked":"Enter locked keywords","selectExcluded":"Enter excluded keywords","selectOptional":"Enter optional keywords","selectCategories":"Select company type","selectLocations":"Enter country, state or city","selectMinEmployees":"Min.","selectMaxEmployees":"Max.","selectMinFoundingYear":"Min.","selectMaxFoundingYear":"Max.","industries":"Industries","locked":"Lock keywords","excluded":"Exclude keywords","optional":"Optional keywords","categories":"Type of company","resultTypes":"Result types","locations":"Locations","companySize":"Number of employees","foundingYearRange":"Founding year","noLocations":"No locations","to":"to","filter":"Filter","clearFilters":"Clear filters","showResults":"Show {resultCount} results","back":"Close","MANUFACTURER":"Manufacturer","DISTRIBUTOR":"Distributor","SERVICE_PROVIDER":"Service provider","EDUCATIONAL_INSTITUTION":"Educational institution","PRODUCT":"Products","SERVICE":"Services","DESCRIPTION":"Core business","companyStatus":"Company status","companyStatusPlaceholder":"Select company status preset","companyStatusOptions":{"startUp":"Start up","medium":"Medium-Sized","enterprise":"Enterprise"}},"header":{"new":"new!","claimNow":"Manage your profile","registerCompany":"Register company","login":"Login"},"selectedFiltersTags":{"industries":"Industries","locked":"Locked keywords","excluded":"Excluded keywords","optional":"Optional keywords","categories":"Categories","locations":"Locations","employeesRange":"Employees","foundingYearRange":"Founding year"},"footer":{"branches":"Industries","caseStudies":"Case studies","platform":"Platform","support":"Support","imprint":"Imprint","privacy":"Privacy policy","terms":"Terms of service","nda":"Non-disclosure agreement"},"cookieConsent":{"title":"This website stores data such as cookies to enable important website functions, including analytics, marketing functions and personalization.","subtitle":"The settings can be adjusted at any time or all cookies can be accepted.","allowAll":"Accept all","allowNecessary":"Allow necessary","customize":"Customize","allowSelected":"Save selected","customizeModalTitle":"Privacy settings","necessary":{"title":"Technically required","description":"These cookies are required for correct functionality of our website and can not be disabled.","services":"1 Service","cookieManager":{"title":"Cookie Manager","description":"The settings of this cookie manager are also stored in its own cookie. This cookie only saves the settings that were made in this manager and is therefore technically required."}},"analytics":{"title":"Analysis","description":"This cookies will gather anonymized statistic information of this website and its users. We will use this information for performance measurement and improvement","services":"1 Service","googleAnalytics":{"title":"Google Analytics","description":"To keep this website in ongoing improvement we analyze the behaviour of our customers by Google Analytics."}}},"companyPageLayout":{"back":"Back to search results"},"companyDetail":{"tabs":{"companyDetails":"About","productsServices":"Products & Services","useCases":"Use Cases","contact":"Contact"},"companyCategory":"This company is: ","employees":"Employees","foundingYear":"Founding year: ","yourCompany":"Is this your company?","featured":"Featured","keywords":"Keywords","industries":"Industries","certifications":"Certifications","useCases":"Use Cases","viewSource":"Visit source","goToWebsite":"Go to website >","claimThisCompany":"Claim this company","view":"View","city":"City","state":"State","country":"Country","noProducts":"This company has no products or services","back":"Back to search results","MANUFACTURER":"Manufacturer","SERVICE_PROVIDER":"Service provider","DISTRIBUTOR":"Distributor","EDUCATIONAL_INSTITUTION":"Educational institution","FROM_1_TO_10":"1-10","FROM_11_TO_50":"11-50","FROM_51_TO_100":"51-100","FROM_101_TO_250":"101-250","FROM_251_TO_500":"251-500","FROM_501_TO_1000":"501-1000","FROM_1001_TO_5000":"1001-5000","FROM_5001_TO_10000":"5001-10000","FROM_10000_UPWARDS":"10001+","selfManaged":"Actively managed by company","productsHeadline":"Product portfolio of","product":"Product","service":"Service","useCase":"Use case","coreBusiness":"Core business","publication":"Publication","verified":"Verified","website":"Website","useCaseHeadline":"Use cases of"},"managedCompanyDetail":{"tabs":{"companyDetails":"About","productsServices":"Products & Services","contact":"Contact","useCases":"Use Cases"},"productsHeadline":"Product portfolio of ","useCaseHeadline":"Use cases of","service":"Service","product":"Product","useCase":"Use case","coreBusiness":"Core business","publication":"Publication","website":"Website","details":"Details","verified":"Verified","companyCategory":"This company is: ","employees":"Employees","foundingYear":"Founding year: ","yourCompany":"Is this your company?","featured":"Featured","keywords":"Keywords","industries":"Industries","certifications":"Certifications","useCases":"Use Cases","viewSource":"Visit source","goToWebsite":"Go to website >","claimThisCompany":"Claim this company","view":"View product >","city":"City","state":"State","country":"Country","noProducts":"This company has no products or services","back":"Back to search results","MANUFACTURER":"Manufacturer","SERVICE_PROVIDER":"Service provider","DISTRIBUTOR":"Distributor","EDUCATIONAL_INSTITUTION":"Educational institution","FROM_1_TO_10":"1-10","FROM_11_TO_50":"11-50","FROM_51_TO_100":"51-100","FROM_101_TO_250":"101-250","FROM_251_TO_500":"251-500","FROM_501_TO_1000":"501-1000","FROM_1001_TO_5000":"1001-5000","FROM_5001_TO_10000":"5001-10000","FROM_10000_UPWARDS":"10001+","selfManaged":"Actively managed by company"},"managedProductDetail":{"contactPerson":"Contact","email":"E-Mail: ","phone":"Phone: ","about":"About this product","type":"Type of product: ","tags":"Tags: ","priceRange":"Price range: ","quantity":"Quantity available: ","shippingRegion":"Shipping region: ","files":"Product files: ","website":"Go to product website","allProducts":"See all products","useCases":"Use cases for this product","view":"View","AFRICA":"Africa","ASIA":"Asia","AUSTRALIA":"Australia","EUROPE":"Europe","NORTH_AMERICA":"North America","SOUTH_AMERICA":"South America","FIRST_PARTY_PRODUCT":"Product","THIRD_PARTY_PRODUCT":"Product","SERVICE":"Service","moreProductsOf":"More products of ","moreUseCasesOf":"More product use cases of "},"useCaseDetail":{"about":"About this use case","type":"Type of product: ","tags":"Tags: ","website":"Go to product website","allProducts":"See all products","relatedProduct":"Related product","viewProduct":"View product","industries":"Industries: ","view":"View","FIRST_PARTY_PRODUCT":"Product","THIRD_PARTY_PRODUCT":"Product","SERVICE":"Service","moreProductsOf":"More products of ","moreUseCasesOf":"More product use cases of "},"searchResultCard":{"FROM_1_TO_10":"1-10","FROM_11_TO_50":"11-50","FROM_51_TO_100":"51-100","FROM_101_TO_250":"101-250","FROM_251_TO_500":"251-500","FROM_501_TO_1000":"501-1000","FROM_1001_TO_5000":"1001-5000","FROM_5001_TO_10000":"5001-10000","FROM_10000_UPWARDS":"10001+","selfManaged":"Actively managed by company","service":"Service","product":"Product","useCase":"Use Case","coreBusiness":"Core business","publication":"Publication"},"noResults":{"noResults":"No results?","tips":"How to search with ensun:","seperateKeywords":"Try to divide your search topic-based into seperate keywords","wrong":"Instead of: ","right":"Try this: ","noLocation":"To fine-tune your search (location, company type, etc.) use the filters","english":"If possible try to search in english"}},"children":["$","$L8",null,{"children":["$","$L9",null,{"children":["$","$La",null,{"children":["$","$L4",null,{"parallelRouterKey":"children","segmentPath":["children",["locale","en","d"],"children"],"error":"$undefined","errorStyles":"$undefined","loading":"$undefined","loadingStyles":"$undefined","hasLoading":false,"template":["$","$L5",null,{}],"templateStyles":"$undefined","notFound":"$Lb","notFoundStyles":[],"childProp":{"current":["$","$L4",null,{"parallelRouterKey":"children","segmentPath":["children",["locale","en","d"],"children","search","children"],"error":"$undefined","errorStyles":"$undefined","loading":"$undefined","loadingStyles":"$undefined","hasLoading":false,"template":["$","$L5",null,{}],"templateStyles":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","childProp":{"current":["$","$L4",null,{"parallelRouterKey":"children","segmentPath":["children",["locale","en","d"],"children","search","children","(static)","children"],"error":"$undefined","errorStyles":"$undefined","loading":"$undefined","loadingStyles":"$undefined","hasLoading":false,"template":["$","$L5",null,{}],"templateStyles":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","childProp":{"current":["$Lc",null],"segment":["slug","nanomedicine","d"]},"styles":[]}],"segment":"(static)"},"styles":[]}],"segment":"search"},"styles":[]}]}]}]}]}],["$","$Ld",null,{"id":"include-tag-manager","strategy":"lazyOnload","src":"https://www.googletagmanager.com/gtag/js?id=G-S6TFT24XP0"}],["$","$Ld",null,{"id":"init-tag-manager","strategy":"lazyOnload","children":"\n window.dataLayer = window.dataLayer || [];\n function gtag(){dataLayer.push(arguments);}\n gtag('js', new Date());\n gtag('config', 'G-S6TFT24XP0', {\n page_path: window.location.pathname,\n });\n gtag('config', 'G-4EZZZL4SBX', {\n page_path: window.location.pathname,\n });\n gtag('config', 'AW-628524800');\n "}]]}]}] b:E{"digest":"NEXT_REDIRECT;replace;https://ensun.io/404"} e:I{"id":"8823","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"IsMobileContextProvider","async":false} f:I{"id":"83030","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"ToggleMobileFiltersContextProvider","async":false} 10:I{"id":"19815","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"SearchPageLayout","async":false} 11:I{"id":"21760","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"Header","async":false} 12:I{"id":"32311","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"SearchPageContentLayout","async":false} 13:I{"id":"9177","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"Filters","async":false} 15:I{"id":"86790","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"AdBanner","async":false} 16:I{"id":"33489","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"Footer","async":false} 17:I{"id":"74289","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","997:static/chunks/997-51add8663fc8b405.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","889:static/chunks/889-f397e0c2afa69472.js","875:static/chunks/875-0aa4a3e290e34c2c.js","777:static/chunks/app/[locale]/search/(static)/[slug]/layout-bdacf8209b2bea5a.js"],"name":"CookieConsent","async":false} c:["$","$Le",null,{"isMobile":false,"children":["$","$Lf",null,{"children":[["$","$L10",null,{"children":[["$","$L11",null,{"query":"Nanomedicine"}],["$","$L12",null,{"children":[["$","$L13",null,{"query":"Nanomedicine"}],["$","$L4",null,{"parallelRouterKey":"children","segmentPath":["children",["locale","en","d"],"children","search","children","(static)","children",["slug","nanomedicine","d"],"children"],"error":"$undefined","errorStyles":"$undefined","loading":"$undefined","loadingStyles":"$undefined","hasLoading":false,"template":["$","$L5",null,{}],"templateStyles":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","childProp":{"current":["$L14",null],"segment":"__PAGE__"},"styles":[]}],["$","$L15",null,{}]]}],["$","$L16",null,{}]]}],["$","$L17",null,{}]]}]}] 18:I{"id":"18617","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"","async":false} 19:I{"id":"23649","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"SearchResultCount","async":false} 1a:I{"id":"15686","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"SearchResultListAdapter","async":false} 1b:I{"id":"99503","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"SearchResultPaginationBar","async":false} 1c:I{"id":"30196","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"SearchDescriptionCard","async":false} 1d:I{"id":"27941","chunks":["884:static/chunks/884-5f6867d114af7093.js","277:static/chunks/277-dd32d7da9703c392.js","963:static/chunks/963-0fe33a576fed3f5d.js","223:static/chunks/223-77ddba23ae0d8aa6.js","934:static/chunks/934-bcd2583cffff9097.js","487:static/chunks/487-3415b4f00268b849.js","771:static/chunks/771-f8f132a25a55c7d1.js","728:static/chunks/728-911b99fa592d7a8a.js","494:static/chunks/494-32f223f6c47b05b2.js","838:static/chunks/app/[locale]/search/(static)/[slug]/page-d9fd041f3fb06c05.js"],"name":"SimilarSearchTags","async":false} 14:[["$","$L15",null,{"format":"horizontal"}],["$","$L18",null,{"keywords":["Nanomedicine"],"products":[{"page":{"__typename":"CrawledPage","_id":"64a90a43f31fd85a2673a037","url":{"entry":"https://sciencepicturecompany.com/portfolio/nanomedicine/","target":"https://sciencepicturecompany.com/portfolio/nanomedicine/"},"content":[{"type":"h1","text":"Journal of Nanomedicine Cover Illustration"},{"type":"p","text":"This cover image for the European Journal of Nanomedicine shows a nanoparticle interacting with a cell membrane. The featured article explores how the protein coating on nanoparticles can influence interactions at biological barriers. Deliverables: Cover Illustration Client: European Journal of Nanomedicine"}],"loadingTime":1.0278337001800537,"lastModifiedAt":"2022-03-01T17:17:26.000Z","metaData":{"title":"Nanomedicine | Science Picture Company","description":"","tags":[],"image":{"internalName":"Nanomedicine_CBNI.jpg","name":"Nanomedicine_CBNI.jpg","url":"https://sciencepicturecompany.com/wp-content/uploads/2022/01/Nanomedicine_CBNI.jpg"}},"classification":{"label":"PRODUCT","isVerified":true}},"score":1745.2988,"company":{"_id":"64a90a2807b69489a80ff550","name":"Science Picture Company","description":"We are an award winning 3D medical animation studio, renowned for creating cinematic 3D visualizations in the fields of science, medicine and technology.","categories":["SERVICE_PROVIDER"],"employeeCountRange":"FROM_1_TO_10","foundingYear":2008,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/the-science-picture-company","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Medical Animation","Mechanism-of-action Animation","Scientific Illustrations","Health Apps","Anatomical illustrations","Medical Device Visualizations","Animation"],"websiteUrl":{"entry":"https://sciencepicturecompany.com/","target":"https://sciencepicturecompany.com/"},"logo":{"internalName":"3c735e11ee836c6d56ead7a14fa0b5_1656693806.jpg","name":"3c735e11ee836c6d56ead7a14fa0b5_1656693806.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a90a2807b69489a80ff550"},"certifications":[],"location":{"_id":"64b66a1902a36268794b8815","city":"Dublin","state":"Leinster","country":"Ireland","countryCode":"IE"},"industries":[{"_id":"60dc4354637b44ca344b2cbb","name":"Media and Entertainment"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fcd46fff7fa46b233d25","url":{"entry":"https://booksmart.sg/products/boron-nitride-nanotubes-in-nanomedicine/","target":"https://booksmart.store/products/boron-nitride-nanotubes-in-nanomedicine?shpxid=3a765d4b-4fd7-400b-99dd-6c2d7e46817c"},"content":[{"type":"p","text":"Home Health Systems & Services Boron Nitride Nanotubes in..."},{"type":"h1","text":"Boron Nitride Nanotubes in Nanomedicine"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Gianni Ciofani"},{"type":"p","text":"Format: Hardback | 246 pages"},{"type":"p","text":"Dimensions:191 x 235 x 16mm | 630g"},{"type":"p","text":"Publication Date: 21 Apr 2016"},{"type":"p","text":"Publisher: William Andrew Publishing"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 0323389457"},{"type":"p","text":"ISBN 13: 9780323389457"},{"type":"h3","text":"Qickview"}],"loadingTime":0.9021282196044922,"lastModifiedAt":"2023-04-20T10:00:27.000Z","metaData":{"title":"Boron Nitride Nanotubes in Nanomedicine– Booksmart","description":"Boron Nitride Nanotubes in Nanomedicine","tags":["Boron Nitride Nanotubes in Nanomedicine,Health Systems & Services,Medical Equipment & Techniques,Medical Toxicology,Neurology & Clinical Neurophysiology,Pharmacology,Pharmacology","Toxicology & Pharmaceutical Science Serials,Physiology,Pre-clinical Medicine: Basic Sciences,Health Systems & Services,Medical Equipment & Techniques,Medical Toxicology,Neurology & Clinical Neurophysiology,Pharmacology,Physiology,Pre-clinical Medicine: Basic Sciences,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1421.7303,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fce3f870e2f61753a7fc","url":{"entry":"https://booksmart.sg/products/3d-printing-technology-in-nanomedicine/","target":"https://booksmart.store/products/3d-printing-technology-in-nanomedicine?shpxid=1a164821-3b82-48d6-81ff-8381327ee813"},"content":[{"type":"p","text":"Home Agriculture 3D Printing Technology in..."},{"type":"h1","text":"3D Printing Technology in Nanomedicine"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Nabeel Ahmad"},{"type":"p","text":"Format: Paperback |128158905pages"},{"type":"p","text":"Dimensions:191 x 235 x 10.92mm | 410g"},{"type":"p","text":"Publication Date: 43553"},{"type":"p","text":"Publisher: Elsevier Science Publishing Co Inc"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 128158905"},{"type":"p","text":"ISBN 13: 9780128158906"},{"type":"h3","text":"Qickview"}],"loadingTime":0.37740063667297363,"lastModifiedAt":"2023-04-21T09:19:44.000Z","metaData":{"title":"3D Printing Technology in Nanomedicine– Booksmart","description":"3D Printing Technology in Nanomedicine","tags":["3D Printing Technology in Nanomedicine,Agriculture,Biomedical & Life Sciences,Biomedical Engineering,Biotechnology,Materials Science,Medicine","Nursing & Dentistry,Biomedical Engineering,Biotechnology,Materials Science,Nanotechnology,Printing & Reprographic Technology,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1421.7303,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fce4d40045d88b7943fa","url":{"entry":"https://booksmart.sg/products/nanomedicine-a-soft-matter-perspective/","target":"https://booksmart.store/products/nanomedicine-a-soft-matter-perspective?shpxid=eaa7e24a-d80e-412d-ac27-e73469547779"},"content":[{"type":"p","text":"Home Biomedical & Life Sciences Nanomedicine : A Soft..."},{"type":"h1","text":"Nanomedicine : A Soft Matter Perspective"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Dipanjan Pan"},{"type":"p","text":"Format: Hardback |1466572825pages"},{"type":"p","text":"Dimensions:156 x 234 x 17.78mm | 476g"},{"type":"p","text":"Publication Date: 41855"},{"type":"p","text":"Publisher: Taylor & Francis Inc"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 1466572825"},{"type":"p","text":"ISBN 13: 9781466572829"},{"type":"h3","text":"Qickview"}],"loadingTime":2.393026351928711,"lastModifiedAt":"2023-04-21T09:11:43.000Z","metaData":{"title":"Nanomedicine : A Soft Matter Perspective– Booksmart","description":"Nanomedicine : A Soft Matter Perspective","tags":["Nanomedicine : A Soft Matter Perspective,Biomedical & Life Sciences,Biomedical Engineering,Materials Science,Medical Equipment & Techniques,Medicine","Nursing & Dentistry,Physics Books,Radiology,Biomedical Engineering,General Practice,Materials Science,Medical Equipment & Techniques,Nanotechnology,Physics Books,Radiology,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1421.7303,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"649d016595532dd264f3c662","url":{"entry":"https://ardena.com/services/nanomedicines/","target":"https://ardena.com/services/nanomedicines/"},"content":[{"type":"p","text":"Home Services Nanomedicines"},{"type":"h1","text":"Nanomedicines development and manufacturing"},{"type":"p","text":"We help you scale up to clinical schedules on time, guiding your nanomedicine candidate through its journey to the clinic and de-risk development with expertise encompassing scalable formulation, process and analytical development."},{"type":"h2","text":"Decomplicating Nanomedicines"},{"type":"p","text":"This fast-evolving field uses nanoscale or nanostructured materials to impart unique pharmacokinetic and therapeutic effects such as targeted delivery, enhanced efficacy and reduced toxicity."},{"type":"p","text":"Our team members have a unique scientific understanding of nanomedicines having advanced a range of formulations into the clinic. We bring this expertise to your project, using established methodologies and innovating when needed to give you the best possible outcomes."},{"type":"p","text":"De-complicating your projects with an integrated approach, our experts take ownership of the technology transfer of your existing process and the implementation of cGMP manufacturing as well as the synthesis of your lipids, polymers and other building blocks."},{"type":"p","text":"Synthesis of building blocks Nanoparticle expertise Process Development GMP Production Analytical Development CMC Regulatory"},{"type":"h2","text":"Synthesis of building blocks"},{"type":"p","text":"We support the development and manufacturing of building blocks necessary for the preparation of nanoparticles in addition to active pharmaceutical ingredients."},{"type":"p","text":"This includes:"},{"type":"p","text":"Custom lipids Monomers Polymers Inorganic complexes"},{"type":"h2","text":"Nanoparticle expertise"},{"type":"p","text":"We integrate analytical development for these APIs and building blocks alongside nanoparticle development to accelerate and de-risk your program."},{"type":"p","text":"We are experts in the following nanoparticles:"},{"type":"p","text":"Liposomes, lipid micelles and lipid nanoparticles Polymeric micelles and polymeric nanoparticles Iron oxide nanoparticles Silica nanoparticles Gold nanoparticles"},{"type":"p","text":" "},{"type":"h2","text":"Nanomedicine Process Development"},{"type":"p","text":"Our scientists develop phase-appropriate production processes in accordance with cGMP and mitigate technology transfer issues by using the same teams for development and manufacturing."},{"type":"p","text":"Techniques include:"},{"type":"p","text":"Flow manufacturing Batchwise synthesis Tangential flow filtration Magnetic separation Single-use purification systems Low bioburden and sterilizing filtrations"},{"type":"h2","text":"GMP Nanomedicine Production"},{"type":"p","text":"In our cGMP-compliant manufacturing facilities, we can produce volumes of a couple of milliliters to up to 300L in some instances, using batch-type and flow manufacturing processes."},{"type":"p","text":"We can handle highly potent drug substances in carefully engineered facilities and can deliver nanosuspensions and nanoparticle solutions as sterile finished drug products in vials or syringes."},{"type":"h2","text":"Analytical Development"},{"type":"p","text":"We are intimately familiar with defining the critical quality attributes (CQAs) of nanomedicines. To evaluate the CQAs of your GMP-produced drug products and to support product development, we utilize state-of-the-art analytical techniques."},{"type":"p","text":"We perform ICH-compliant stability testing of nanomedicines, APIs and novel excipients using stability indicating methods."},{"type":"h3","text":"Analytical techniques used"},{"type":"p","text":"Dynamic light scattering, Small-angle X-ray scattering Capillary electrophoresis Zeta-potential measurements Transmission and scanning electron microscopy Dynamic light scattering, small-angle X-ray scattering and laser diffraction Asymmetric flow field-flow fractionation – multi-angle light scattering (AF4-MALS) Size exclusion chromatography Zeta potential measurements Nuclear magnetic resonance, infrared and Raman spectroscopy HPLC/UPLC"},{"type":"h2","text":"Dossier Development and Strategic Regulatory Support"},{"type":"p","text":"Having advanced a wide range of nanomedicine formulations into the clinic, we are used to developing new manufacturing techniques and analytical procedures under fierce regulatory scrutiny."},{"type":"p","text":"Our dossier-oriented approach combined with deep understanding of the regulatory landscape gives your nanomedicine project the greatest chance of approval."},{"type":"h2","text":"Related Resources"},{"type":"p","text":"Our expert team members share their deep, scientific understanding and insights into nanomedicine development and manufacturing"},{"type":"h3","text":"On-demand webinar: Mastering Nanomedicines Characterization: Techniques for Determining Particle Size Distribution Based on Dynamic Light Scattering"},{"type":"h3","text":"Using Flow Technology in Nanoparticle Synthesis"},{"type":"h3","text":"Advancing oligonucleotide therapeutics with cutting-edge bioanalytics"},{"type":"h3","text":"Fit-for-Phase Nanomedicine Solutions"},{"type":"h3","text":"Deciphering the complex characteristics of nanoparticles by asymmetric flow field-flow fractionation"},{"type":"h3","text":"Navigating the CMC Regulatory Landscape for Oligonucleotide Therapeutics"},{"type":"h2","text":"Our integrated platforms"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your small molecule drug development."},{"type":"h3","text":"Drug substance"},{"type":"p","text":"Helping you turn your compounds that show promise into GMP-grade drug substances."},{"type":"p","text":"Process developmentAnalytical developmentSolid State ResearchAPI manufacturing"},{"type":"h3","text":"Drug product"},{"type":"p","text":"We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services."},{"type":"p","text":"FormulationAnalytical methodsGMP manufacturingClinical Supply"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline preparation and submission of your registration file."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your large molecule drug development."},{"type":"h3","text":"Drug product"},{"type":"p","text":"We advance your large molecule candidates through the pipeline quickly and safely with specialist drug product services."},{"type":"p","text":"FormulationAnalytical methodsAseptic manufacturingClinical Supply"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your large molecule drugs through preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your nanomedicine drug development."},{"type":"h3","text":"Drug product"},{"type":"p","text":"We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services."},{"type":"p","text":"Building block synthesisProcess developmentGMP productionAnalytical development"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"}],"loadingTime":0.6642704010009766,"lastModifiedAt":"2023-03-17T10:49:00.000Z","metaData":{"title":"Nanomedicines Development | Nanomedicines Manufacturing | Nanosuspension Formulation","description":"Ardena are a CDMO that provide nanomedicine development and manufacturing services guiding your nanomedicine candidate through its journey to the clinic.","tags":[],"image":null},"classification":{"label":"SERVICE","isVerified":true}},"score":1342.2585,"company":{"_id":"649d0154f4f83c1d9a6bc75a","name":"Ardena Group","description":"With deep scientific expertise, Ardena reliably guides you and your molecule through the challenging terrain of innovative drug development. By seamlessly integrating our services, we’re able to better mitigate development risks and ultimately reduce time-to-clinic. Our facilities are carefully engineered and uniquely built to support and enable early phase development for our partners' oral drugs, injectables and nanomedicines. We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services. Our comprehensive CMC regulatory services streamline preparation and submission of your registration file. Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug. We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services. Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines.","categories":["EDUCATIONAL_INSTITUTION","SERVICE_PROVIDER","MANUFACTURER"],"employeeCountRange":"FROM_251_TO_500","foundingYear":1994,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/one-ardena","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":"https://www.crunchbase.com/organization/ardena-group","dnbUrl":null},"keywords":["API","Regulatory & scientific writing","Drug Product","Nanomedicines","GMP Manufacturing","Drug Substance","Clinical logistics","Pharmaceuticals","Pharmaceutical","Contract Development & Manufacturing Organization","Pharmaceutical company","Formulation development","CDMO","Pharma","Health Care","Solid state research","Bioanalytics"],"websiteUrl":{"entry":"http://ardena.com/","target":"https://ardena.com/"},"logo":{"internalName":"eb060ae1f2fa7ff72d356b7dce8959_1642874181.jpg","name":"eb060ae1f2fa7ff72d356b7dce8959_1642874181.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649d0154f4f83c1d9a6bc75a"},"certifications":[],"location":{"_id":"64b66a1b02a36268794b88d8","city":"Ghent","state":"East Flanders","country":"Belgium","countryCode":"BE"},"industries":[{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fcdb5162b7819b8c9881","url":{"entry":"https://booksmart.sg/products/theory-and-applications-of-nonparenteral-nanomedicines/","target":"https://booksmart.store/products/theory-and-applications-of-nonparenteral-nanomedicines?shpxid=69546209-4469-4dda-b96e-11ad9f168234"},"content":[{"type":"p","text":"Home Agriculture Theory and Applications of..."},{"type":"h1","text":"Theory and Applications of Nonparenteral Nanomedicines"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Prashant Kesharwani"},{"type":"p","text":"Format: Paperback |128204664pages"},{"type":"p","text":"Dimensions:191 x 235 x 27.69mm | 1,020g"},{"type":"p","text":"Publication Date: 44090"},{"type":"p","text":"Publisher: Elsevier Science Publishing Co Inc"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 128204664"},{"type":"p","text":"ISBN 13: 9780128204665"},{"type":"h3","text":"Qickview"}],"loadingTime":2.780400276184082,"lastModifiedAt":"2023-04-21T09:18:56.000Z","metaData":{"title":"Theory and Applications of Nonparenteral Nanomedicines– Booksmart","description":"Theory and Applications of Nonparenteral Nanomedicines","tags":["Theory and Applications of Nonparenteral Nanomedicines,Agriculture,Biomedical & Life Sciences,Biomedical Engineering,Biotechnology,Materials Science,Medical Equipment & Techniques,Medicine","Nursing & Dentistry,Pharmaceutical Industries,Pharmacology,Pharmacology","Toxicology & Pharmaceutical Science Serials,Biomedical Engineering,Biotechnology,Materials Science,Medical Equipment & Techniques,Pharmaceutical Industries,Pharmacology,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1339.9379,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fce7fea53f8119a8145b","url":{"entry":"https://booksmart.sg/products/intelligent-polymers-for-nanomedicine-and-biotechnologies/","target":"https://booksmart.store/products/intelligent-polymers-for-nanomedicine-and-biotechnologies?shpxid=7957c2a8-27a2-417c-bee6-42c4beb5c613"},"content":[{"type":"p","text":"Home Agriculture Intelligent Polymers for Nanomedicine..."},{"type":"h1","text":"Intelligent Polymers for Nanomedicine and Biotechnologies"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Magdalena Aflori"},{"type":"p","text":"Format: Paperback | 244 pages"},{"type":"p","text":"Dimensions:156 x 235 x 19.05mm | 318g"},{"type":"p","text":"Publication Date: 28 Sep 2017"},{"type":"p","text":"Publisher: Taylor & Francis Ltd"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 1138746452"},{"type":"p","text":"ISBN 13: 9781138746459"},{"type":"h3","text":"Qickview"}],"loadingTime":14.101569652557373,"lastModifiedAt":"2023-04-21T10:41:14.000Z","metaData":{"title":"Intelligent Polymers for Nanomedicine and Biotechnologies– Booksmart","description":"Intelligent Polymers for Nanomedicine and Biotechnologies","tags":["Intelligent Polymers for Nanomedicine and Biotechnologies,Agriculture,Biomedical & Life Sciences,Biotechnology,Chemistry & Material Sciences,Materials Science,Medical Equipment & Techniques,Plastics & Polymers Technology,Taylor & Francis Ltd,Biotechnology,General Practice,Materials Science,Medical Equipment & Techniques,Plastics & Polymers Technology,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1339.9379,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fcd130fc7ef36ff5d06c","url":{"entry":"https://booksmart.sg/products/nanomaterials-for-clinical-applications-case-studies-in-nanomedicines/","target":"https://booksmart.store/products/nanomaterials-for-clinical-applications-case-studies-in-nanomedicines?shpxid=29c5e783-89aa-44ca-8818-088332375aac"},"content":[{"type":"p","text":"Home Materials Science Nanomaterials for Clinical Applications..."},{"type":"h1","text":"Nanomaterials for Clinical Applications : Case Studies in Nanomedicines"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Costas Demetzos"},{"type":"p","text":"Format: Paperback | 322 pages"},{"type":"p","text":"Dimensions:191 x 235 x 17.02mm | 660g"},{"type":"p","text":"Publication Date: 15 Feb 2020"},{"type":"p","text":"Publisher: Elsevier Science Publishing Co Inc"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 012816705X"},{"type":"p","text":"ISBN 13: 9780128167052"},{"type":"h3","text":"Qickview"}],"loadingTime":0.6602773666381836,"lastModifiedAt":"2023-04-21T13:13:09.000Z","metaData":{"title":"Nanomaterials for Clinical Applications : Case Studies in Nanomedicine– Booksmart","description":"Nanomaterials for Clinical Applications : Case Studies in Nanomedicines","tags":["Nanomaterials for Clinical Applications : Case Studies in Nanomedicines,Materials Science,Materials Science,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1201.7792,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"64a2fd013c1d8b7f87cddc79","url":{"entry":"https://booksmart.sg/products/advances-in-nanomedicine-for-the-delivery-of-therapeutic-nucleic-acids/","target":"https://booksmart.store/products/advances-in-nanomedicine-for-the-delivery-of-therapeutic-nucleic-acids?shpxid=b4d858fd-9712-41a5-a021-6b22d592fef3"},"content":[{"type":"p","text":"Home Gene Therapy Advances in Nanomedicine for..."},{"type":"h1","text":"Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Free delivery worldwide"},{"type":"p","text":"Receive the books within 3-12 business days."},{"type":"p","text":"Why buy from Booksmart ?"},{"type":"p","text":"100% Authentic Books Customer Satisfaction is our no. 1 Priority Secure Payment"},{"type":"p","text":"Product Details"},{"type":"h2","text":"Product details"},{"type":"p","text":"Author: Surendra Nimesh"},{"type":"p","text":"Format: Hardback | 256 pages"},{"type":"p","text":"Dimensions:152 x 229 x 16mm | 540g"},{"type":"p","text":"Publication Date: 20 Apr 2017"},{"type":"p","text":"Publisher: ELSEVIER SCIENCE & TECHNOLOGY"},{"type":"p","text":"Language: English"},{"type":"p","text":"ISBN 10: 0081005571"},{"type":"p","text":"ISBN 13: 9780081005576"},{"type":"h3","text":"Qickview"}],"loadingTime":0.35883188247680664,"lastModifiedAt":"2023-04-20T09:20:33.000Z","metaData":{"title":"Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids– Booksmart","description":"Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids","tags":["Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids,Gene Therapy,Molecular Biology,Pharmacology,Pharmacology","Toxicology & Pharmaceutical Science Serials,Gene Therapy,Molecular Biology,Nanotechnology,Pharmacology,Booksmart","booksmart.sg"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1089.5374,"company":{"_id":"64a2f46b77d2f1434aea13df","name":"Booksmart","description":null,"categories":["MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2021,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/booksmartstore","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["Retail"],"websiteUrl":{"entry":"http://www.booksmart.store/","target":"https://booksmart.store/"},"logo":{"internalName":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","name":"addf9657a57ba7e6db9492ec06e1f0_1657174578.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a2f46b77d2f1434aea13df"},"certifications":[],"location":{"_id":"64b671515cca02372672f733","city":"Singapore","state":"Southwest","country":"Singapore","countryCode":"SG"},"industries":[{"_id":"60dc4355637b44ca344b2cc6","name":"Commerce and Shopping"}]}},{"page":{"__typename":"CrawledPage","_id":"649c3753d987cefae88e1590","url":{"entry":"https://www.tlcbio.com/en-global/technology/index/targeted-delivery/active-targeting","target":"https://www.tlcbio.com/en-global/technology/index/targeted-delivery/active-targeting"},"content":[{"type":"h2","text":"Technology"},{"type":"h1","text":"Antibody-Linked Nanomedicines"},{"type":"p","text":"TLC is using antibodies and antibody fragments attached to lipid encapsulated drugs to develop more effective therapies in oncology. These antibody-linked nanomedicines actively target specific tissues using binding interactions between a specific antibody and a target antigen on the surface of a particular cell type. Compared with passively targeted therapies, these nanomedicines are better able to reach tissues farther from blood vessels and improve the biodistribution of the therapeutic payload. In addition, lipid-based antibody-linked nanomedicines can deliver a higher quantity of payload molecules compared to other actively targeted therapies like antibody-drug conjugates (ADCs). While ADC’s are capable of delivering 3 to 4 molecules of payload for each linked antibody, TLC’s nanomedicines are capable of delivering approximately 10,000 molecules with less than 100 antibodies. This approach is far more efficient and will likely translate into new treatments with higher efficacy. TLC’s development of antibody-linked nanomedicines builds on past successes in improving the delivery of cytotoxic drugs for therapies in oncology.  "},{"type":"p","text":"TLC is using antibodies and antibody fragments attached to lipid encapsulated drugs to develop more effective therapies in oncology. These antibody-linked nanomedicines actively target specific tissues using binding interactions between a specific antibody and a target antigen on the surface of a particular cell type. Compared with passively targeted therapies, these nanomedicines are better able to reach tissues farther from blood vessels and improve the biodistribution of the therapeutic payload. In addition, lipid-based antibody-linked nanomedicines can deliver a higher quantity of payload molecules compared to other actively targeted therapies like antibody-drug conjugates (ADCs). While ADC’s are capable of delivering 3 to 4 molecules of payload for each linked antibody, TLC’s nanomedicines are capable of delivering approximately 10,000 molecules with less than 100 antibodies. This approach is far more efficient and will likely translate into new treatments with higher efficacy. TLC’s development of antibody-linked nanomedicines builds on past successes in improving the delivery of cytotoxic drugs for therapies in oncology."},{"type":"p","text":"  Application Active targeting to disease site Advantages Active targeting Internalization of target liposome"},{"type":"p","text":"Application"},{"type":"p","text":"Active targeting to disease site"},{"type":"p","text":"Advantages"},{"type":"p","text":"Active targeting Internalization of target liposome"},{"type":"p","text":"Active targeting Internalization of target liposome"},{"type":"p","text":"About Company Overview Management Board of Directors Corporate Responsibility Pipeline Overview Pain Management Ophthalmology Oncology Infectious Diseases Technology Sustained Release Targeted Delivery Other Technologies Pressroom Press Releases Media Library Publications Careers Benefits Job Opportunities Contact Us"},{"type":"p","text":"Company Overview Management Board of Directors Corporate Responsibility"},{"type":"p","text":"Overview Pain Management Ophthalmology Oncology Infectious Diseases"},{"type":"p","text":"Sustained Release Targeted Delivery Other Technologies"},{"type":"p","text":"Press Releases Media Library Publications"},{"type":"p","text":"Benefits Job Opportunities"}],"loadingTime":5.901382207870483,"lastModifiedAt":null,"metaData":{"title":"Technology-TLC","description":"","tags":["Technology,TLC"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}},"score":1035.26,"company":{"_id":"649c370dfe5141901d2c80ca","name":"Taiwan Liposome","description":"TLC is dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. TLC is dedicated to the research, development, and commercialization of best-in-class novel lipid nanoparticle (LNP)-based medicines.","categories":["MANUFACTURER"],"employeeCountRange":"FROM_101_TO_250","foundingYear":1997,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/tlcbio","facebookUrl":"https://www.facebook.com/tlcbiopharm/","twitterUrl":"https://www.twitter.com/tlcbio","crunchbaseUrl":"https://www.crunchbase.com/organization/the-liposome-company","dnbUrl":"https://www.dnb.com/business-directory/company-profiles.taiwan_liposome_co_ltd.1081d8d2b163d1ce2da3627ecc02e0f5.html"},"keywords":["Osteoarthritis","Ophthalmology","Drug Delivery","Medical and Diagnostic Laboratories","Professional, Scientific, and Technical Services","Pain Management","Biological laboratory","Drug Discovery","Oncology","Nanomedicine","Industry specialist consultants","Health Care","Biotechnology","Management, Scientific, and Technical Consulting Services","Drug Development","Medical"],"websiteUrl":{"entry":"http://www.tlcbio.com/","target":"https://www.tlcbio.com/"},"logo":{"internalName":"61d5f5992c676788ada6ae09_1642615865.jpg","name":"61d5f5992c676788ada6ae09_1642615865.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649c370dfe5141901d2c80ca"},"certifications":[],"location":{"_id":"64b66a1802a36268794b879e","city":"Taipei","state":null,"country":"Taiwan","countryCode":"TW"},"industries":[{"_id":"60dc4354637b44ca344b2cc1","name":"Professional Services"},{"_id":"60dc4354637b44ca344b2cb4","name":"Science and Engineering"},{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"},{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"}]}}]}],["$","$L19",null,{"keywords":["Nanomedicine"],"resultCount":56}],["$","$L1a",null,{"results":[{"company":{"__typename":"CrawledCompanyOverview","_id":"649d80f9f01e4d8ba66255bf","name":"Cuprous Pharmaceuticals","description":"At Cuprous, we specialize in developing technologies that result in the creation of novel, best-in-class small molecules by overcoming developmental barriers and improving safety and therapeutic activity. Cuprous offers its enabling technologies to its partners to create best-in-class nanomedicines to address unmet medical needs.","categories":["SERVICE_PROVIDER","MANUFACTURER"],"employeeCountRange":"FROM_1_TO_10","foundingYear":2016,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/cuprous-pharmaceuticals","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":"https://www.crunchbase.com/organization/cuprous-pharmaceuticals","dnbUrl":null},"keywords":["Biopharma","Biotechnology","Medical","Pharmaceutical"],"websiteUrl":{"entry":"https://www.cuprous.ca/","target":"https://www.cuprous.ca/"},"logo":{"internalName":"8d1e93171d4a00959192d8b21f5bc2_1643800218.jpg","name":"8d1e93171d4a00959192d8b21f5bc2_1643800218.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649d80f9f01e4d8ba66255bf"},"certifications":[],"location":{"_id":"64b66a1402a36268794b8681","city":"Vancouver","state":"British Columbia","country":"Canada","countryCode":"CA"},"industries":[{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"},{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"},{"_id":"60dc4354637b44ca344b2cb4","name":"Science and Engineering"}]},"score":868.19257,"pageHits":[{"score":3355.5476,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["Cuprous Pharmaceuticals provides partners with technologies and expertise in developing small molecule nanomedicines addressing solubility issues, reducing Cmax related toxicities, and improving therapeutic activity for pre-clinical and clinical use."]},{"location":"descriptionPage.h3","snippets":["MARCEL BALLY IS ONE OF THE SPEAKERS ON VANCOUVER NANOMEDICINE DAY!"]},{"location":"descriptionPage.metaTitle","snippets":["Home | Cuprous Pharmaceuticals (CPI) | Nanomedicines | Vancouver"]}],"page":{"_id":"649d810a9c0c23b7b0b6bf50","url":{"entry":"https://www.cuprous.ca","target":"https://www.cuprous.ca"},"content":[{"type":"h1","text":"CUPROUS PHARMACEUTICALS"},{"type":"p","text":"Providing partners with technologies to create best-in-class nanomedicines"},{"type":"h2","text":"INNOVATE & COLLABORATE"},{"type":"p","text":"THIS IS WHAT WE DO"},{"type":"h3","text":"NANOTECHNOLOGIES"},{"type":"p","text":"At Cuprous, we specialize in developing technologies that result in the creation of novel, best-in-class small molecules by overcoming developmental barriers and improving safety and therapeutic activity."},{"type":"h3","text":"PARTNERSHIPS"},{"type":"p","text":"Cuprous offers its enabling technologies to its partners to create best-in-class nanomedicines to address unmet medical needs."},{"type":"h2","text":"NEWSROOM"},{"type":"h3","text":"DR. MARCEL BALLY IS ONE OF THE SPEAKERS ON VANCOUVER NANOMEDICINE DAY!"},{"type":"p","text":"September 14, 2020"},{"type":"p","text":"Don't miss out on the upcoming Vancouver Nanomedicine Day this week on September 17, 2020! Our Founder and CSO, Dr. Marcel Bally will be speaking about \"Metals in Liposomes\". There will also be an exciting debate on whether “Nanomedicines are still the next big thing” between Dr. Marcel Bally (proponent) and Dr. Kishor Wasan (opponent)."},{"type":"h2","text":"THE CUPROUS TEAM"},{"type":"h3","text":"THOMAS REDELMEIER, PHD"},{"type":"p","text":"Founder, CEO & President"},{"type":"h3","text":"MICHAEL ABRAMS, PHD"},{"type":"p","text":"Vice President, Research"},{"type":"h3","text":"MARCEL BALLY, PHD"},{"type":"p","text":"Founder, Chief Scientific Officer"},{"type":"h3","text":"ADA LEUNG, PHD"},{"type":"p","text":"Founder, Director of Operations"},{"type":"h3","text":"GHANIA CHIKH, PHD"},{"type":"p","text":"Scientific Advisor"},{"type":"h2","text":"GET IN TOUCH"},{"type":"p","text":"Thanks for submitting!"}],"loadingTime":0.15591764450073242,"lastModifiedAt":null,"metaData":{"title":"Home | Cuprous Pharmaceuticals (CPI) | Nanomedicines | Vancouver","description":"Cuprous Pharmaceuticals provides partners with technologies and expertise in developing small molecule nanomedicines addressing solubility issues, reducing Cmax related toxicities, and improving therapeutic activity for pre-clinical and clinical use.","tags":["copper","formulation","liposomes","metal complexes","nanotechnology","poorly soluble","small molecules"],"image":null},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"649e6351f01e4d8ba6625a84","name":"Arrogene","description":"Arrogene, Inc., was founded in 2006, to commercialize both a new targeted cancer treatment technology and a proprietary molecular delivery platform aimed at inhibiting and ultimately stopping, tumor progression. Arrogene has licensed technologies and patents for its core technology–Polycefin™–from Cedars-Sinai Medical Center (CSMC) in Los Angeles, one of the nation’s premiere research institutions. The founders of Arrogene were principally involved in the research and development of Polycefin™–a breakthrough biopolymer-based nano delivery platform, capable of targeted delivery of protein, peptide, small molecule or olignucleotide therapeutics. Work on Polycefin™ involved eight years of development and nearly $30 million in grants funded by the National Institutes of Health (NIH) and other foundations. Our production laboratory has the know-how to engineer nanoconjugates rapidly and reliably, and support in vitro and in vivo characterization.","categories":["MANUFACTURER"],"employeeCountRange":"FROM_1_TO_10","foundingYear":2007,"digitalPresence":{"linkedinUrl":null,"facebookUrl":null,"twitterUrl":"http://twitter.com/Arrogene","crunchbaseUrl":"https://www.crunchbase.com/organization/arrogene","dnbUrl":"https://www.dnb.com/business-directory/company-profiles.arrogene_inc.ff54fbbc18c26019.html"},"keywords":["Health Diagnostics","Scientific Research and Development Services","Biotechnical research, commercial","Biotechnology","Professional, Scientific, and Technical Services"],"websiteUrl":{"entry":"http://arrogene.com/","target":"https://arrogene.com/"},"logo":{"internalName":"ea921caa671e52f97ba786ca638a87_1648488244.jpg","name":"ea921caa671e52f97ba786ca638a87_1648488244.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649e6351f01e4d8ba6625a84"},"certifications":[],"location":{"_id":"64b66a1a02a36268794b8847","city":"Santa Monica","state":"California","country":"United States","countryCode":"US"},"industries":[{"_id":"60dc4354637b44ca344b2cc1","name":"Professional Services"},{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"},{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"},{"_id":"60dc4354637b44ca344b2cb4","name":"Science and Engineering"}]},"score":648.00543,"pageHits":[{"score":4762.545,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["PREMIER RESEARCH LEADING TO PREMIER NANOMEDICINES \r\nArrogene, Inc., was founded in 2006, to commercialize both a new targeted cancer treatment technology and a proprietary"]},{"location":"descriptionPage.h1","snippets":["PREMIER RESEARCH LEADING TO PREMIER NANOMEDICINES"]}],"page":{"_id":"649e63a15ffd91e1044585d3","url":{"entry":"https://arrogene.com/company/","target":"https://arrogene.com/company/"},"content":[{"type":"h1","text":"PREMIER RESEARCH LEADING TO PREMIER NANOMEDICINES"},{"type":"h1","text":"PREMIER RESEARCH LEADING TO PREMIER NANOMEDICINES"},{"type":"p","text":"Arrogene, Inc., was founded in 2006, to commercialize both a new targeted cancer treatment technology and a proprietary molecular delivery platform aimed at inhibiting and ultimately stopping, tumor progression. Arrogene has licensed technologies and patents for its core technology–Polycefin™–from Cedars-Sinai Medical Center (CSMC) in Los Angeles, one of the nation’s premiere research institutions. The founders of Arrogene were principally involved in the research and development of Polycefin™–a breakthrough biopolymer-based nano delivery platform, capable of targeted delivery of protein, peptide, small molecule or olignucleotide therapeutics. "},{"type":"p","text":"Work on Polycefin™ involved eight years of development and nearly $30 million in grants funded by the National Institutes of Health (NIH) and other foundations. "},{"type":"h2","text":"Our Partnering Strategy"},{"type":"h2","text":"Arrogene is actively seeking partners in both the U.S. and International markets, including pharmaceutical companies with existing cancer therapy drugs or active diagnostic imaging agents as well as biomarkers, that might benefit from better targeting and reduced toxicity."},{"type":"p","text":"Our production laboratory has the know-how to engineer nanoconjugates rapidly and reliably, and support in vitro and in vivo characterization. We have partnered with the Nanotechnology Characterization Laboratory (NCL), the organization created by the National Institute of Standards and Technology (NIST), the U.S. Food and Drug Administration (FDA), and the National Cancer Institute (NCI) to perform preclinical efficacy and toxicity testing of our nanomedicines. NCL has completed the characterization of lead Polycefin™ drug candidates and the data are available to our collaborating partners."},{"type":"h2","text":"Research Collaboration"},{"type":"h2","text":"Because of its ease of conjugation, flexible platform, ability to carry a multiplicity of therapeutic or imaging payloads and its ability to pass through the blood-brain barrier, Polycefin™ also has applications outside the field of oncology. We are experimenting with applications in a wide range of diseases and diagnostics, including neurological diseases, virus targeting, and others."},{"type":"h2","text":"We maintain an active collaboration with research entities that wish to experiment with Polycefin™ as a drug delivery and targeting vehicle."}],"loadingTime":0.45534491539001465,"lastModifiedAt":"2020-10-27T20:34:09.000Z","metaData":{"title":"Our Company - Arrogene","description":"PREMIER RESEARCH LEADING TO PREMIER NANOMEDICINES \r\nArrogene, Inc., was founded in 2006, to commercialize both a new targeted cancer treatment technology and a proprietary","tags":[],"image":{"internalName":"resized-NewArrogeneLogo-Copy.png","name":"resized-NewArrogeneLogo-Copy.png","url":"https://arrogene.com/wp-content/uploads/2020/10/resized-NewArrogeneLogo-Copy.png"}},"classification":{"label":"DESCRIPTION","isVerified":true}}},{"score":4685.2637,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["A NEW GENERATION OF NANOMEDICINES \r\nArrogene is at the forefront of medical technology, creating a new generation of nano agents capable of delivering"]},{"location":"descriptionPage.h1","snippets":["A NEW GENERATION OF NANOMEDICINES"]}],"page":{"_id":"649e63934e7430d4c1f465a7","url":{"entry":"https://arrogene.com/","target":"https://arrogene.com/"},"content":[{"type":"h1","text":"A NEW GENERATION OF NANOMEDICINES"},{"type":"p","text":"Arrogene is at the forefront of medical technology, creating a new generation of nano agents capable of delivering peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging."},{"type":"p","text":"Our technology leads the way in personalized cancer treatment. This unique nanomedicine platform can deliver multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer."},{"type":"p","text":"NEW POSSIBILITIES FOR CANCER TREATMENT"},{"type":"p","text":"♦ Targeted cancer-imaging drugs"},{"type":"p","text":"♦ Immunochemistry for diagnostics and prognostics"},{"type":"p","text":"♦ Readily-tailored, proprietary technology"},{"type":"p","text":"♦ Non-immunogenic, non-toxic bio-polymer based"},{"type":"p","text":"OUR COMPANY"},{"type":"p","text":"OUR TECHNOLOGY"},{"type":"p","text":"OUR TEAM"}],"loadingTime":4.252386569976807,"lastModifiedAt":"2020-10-27T20:34:02.000Z","metaData":{"title":"Home - Arrogene","description":"A NEW GENERATION OF NANOMEDICINES \r\nArrogene is at the forefront of medical technology, creating a new generation of nano agents capable of delivering","tags":[],"image":{"internalName":"Depositphotos_68773101_crop.jpeg","name":"Depositphotos_68773101_crop.jpeg","url":"https://arrogene.com/wp-content/uploads/2016/09/Depositphotos_68773101_crop.jpeg"}},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"64a553334ffc919206effa07","name":"Westwood Bioscience Inc","description":"Nanomedicine is a newly evolving field in which the functions and features of nanoscale objects and systems are used for improved diagnostics, imaging, therapeutics and regenerative medicine.Nanotherapeutics include the use of nanocarriers for drug delivery, with the potential to improve the pharmacokinetics, biodistribution, tissue concentrations and efficacy over the free drug. In addition, encapsulated drug delivery can also reduce the systemic biodistribution and toxicity of potentially hazardous drugs such as chemotherapeutics.The Silicasome is an example of an encapsulated nanocarrier, which is comprised of a mesoporous silica nanoparticle core with a lot of drug packaging space, and surrounded by a lipid bilayer. Westwood Bioscience, Inc., incorporated in 2017, are developing a new nanocarrier technology for improved delivery of chemotherapeutic agents to pancreas and colon cancer tuned to achieve improved efficacy, while reducing toxicity.Work led by Drs. This development has attracted significant attention in the field of pancreas cancer chemotherapy, as the Westwood nanocarrier is capable of delivering a single or ratiometric combination of chemotherapeutic agents to the cancer site, with the ability to overcome the drug resistant in stroma, improve efficacy and improve the toxicity over other nanocarriers used for treating this disease.","categories":[],"employeeCountRange":"FROM_1_TO_10","foundingYear":2018,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/westwood-bioscience-inc","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["nanotechnology","mesoporous silica particles","Drug develpoment","Clinical development","Biotechnology"],"websiteUrl":{"entry":"http://www.westwoodbioscience.com/","target":"https://westwoodbioscience.com/"},"logo":{"internalName":"11619c8115d6889d0e1504a72989ff_1661075217.jpg","name":"11619c8115d6889d0e1504a72989ff_1661075217.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a553334ffc919206effa07"},"certifications":[],"location":{"_id":"64b669811becf261d7eba856","city":"Los Angeles","state":"California","country":"United States","countryCode":"US"},"industries":[{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"}]},"score":354.02573,"pageHits":[{"score":2999.2576,"highlights":[{"location":"descriptionPage.h2","snippets":["What is Nanomedicine?"]}],"page":{"_id":"64a5534569dc4d3383cf800e","url":{"entry":"https://westwoodbioscience.com","target":"https://westwoodbioscience.com"},"content":[{"type":"h2","text":"What is Nanomedicine?"},{"type":"p","text":"Nanomedicine is a newly evolving field in which the functions and features of nanoscale objects and systems are used for improved diagnostics, imaging, therapeutics and regenerative medicine.Nanotherapeutics include the use of nanocarriers for drug delivery, with the potential to improve the pharmacokinetics, biodistribution, tissue concentrations and efficacy over the free drug. In addition, encapsulated drug delivery can also reduce the systemic biodistribution and toxicity of potentially hazardous drugs such as chemotherapeutics.The Silicasome is an example of an encapsulated nanocarrier, which is comprised of a mesoporous silica nanoparticle core with a lot of drug packaging space, and surrounded by a lipid bilayer."},{"type":"h2","text":"Our new technology:"},{"type":"p","text":"Westwood Bioscience, Inc., incorporated in 2017, are developing a new nanocarrier technology for improved delivery of chemotherapeutic agents to pancreas and colon cancer tuned to achieve improved efficacy, while reducing toxicity.Work led by Drs. Andre Nel and Huan Meng’s at UCLA, resulted in the development and preclinical testing of a novel, smart nanocarrier, which we call a Silicasome. This development has attracted significant attention in the field of pancreas cancer chemotherapy, as the Westwood nanocarrier is capable of delivering a single or ratiometric combination of chemotherapeutic agents to the cancer site, with the ability to overcome the drug resistant in stroma, improve efficacy and improve the toxicity over other nanocarriers used for treating this disease."}],"loadingTime":0.5140807628631592,"lastModifiedAt":null,"metaData":{"title":"Westwood Bioscience","description":"","tags":[],"image":null},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"649d0154f4f83c1d9a6bc75a","name":"Ardena Group","description":"With deep scientific expertise, Ardena reliably guides you and your molecule through the challenging terrain of innovative drug development. By seamlessly integrating our services, we’re able to better mitigate development risks and ultimately reduce time-to-clinic. Our facilities are carefully engineered and uniquely built to support and enable early phase development for our partners' oral drugs, injectables and nanomedicines. We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services. Our comprehensive CMC regulatory services streamline preparation and submission of your registration file. Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug. We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services. Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines.","categories":["EDUCATIONAL_INSTITUTION","SERVICE_PROVIDER","MANUFACTURER"],"employeeCountRange":"FROM_251_TO_500","foundingYear":1994,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/one-ardena","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":"https://www.crunchbase.com/organization/ardena-group","dnbUrl":null},"keywords":["API","Regulatory & scientific writing","Drug Product","Nanomedicines","GMP Manufacturing","Drug Substance","Clinical logistics","Pharmaceuticals","Pharmaceutical","Contract Development & Manufacturing Organization","Pharmaceutical company","Formulation development","CDMO","Pharma","Health Care","Solid state research","Bioanalytics"],"websiteUrl":{"entry":"http://ardena.com/","target":"https://ardena.com/"},"logo":{"internalName":"eb060ae1f2fa7ff72d356b7dce8959_1642874181.jpg","name":"eb060ae1f2fa7ff72d356b7dce8959_1642874181.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649d0154f4f83c1d9a6bc75a"},"certifications":[],"location":{"_id":"64b66a1b02a36268794b88d8","city":"Ghent","state":"East Flanders","country":"Belgium","countryCode":"BE"},"industries":[{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"}]},"score":315.5785,"pageHits":[{"score":11819.778,"highlights":[{"location":"verifiedServicePage.h2","snippets":["Decomplicating Nanomedicines"]},{"location":"verifiedServicePage.h3","snippets":["Fit-for-Phase Nanomedicine Solutions"]},{"location":"verifiedServicePage.h1","snippets":["Nanomedicines development and manufacturing"]},{"location":"verifiedServicePage.metaDescription","snippets":["Ardena are a CDMO that provide nanomedicine development and manufacturing services guiding your nanomedicine candidate through its journey to the clinic."]},{"location":"verifiedServicePage.metaTitle","snippets":["Nanomedicines Development | Nanomedicines Manufacturing | Nanosuspension Formulation"]}],"page":{"_id":"649d016595532dd264f3c662","url":{"entry":"https://ardena.com/services/nanomedicines/","target":"https://ardena.com/services/nanomedicines/"},"content":[{"type":"p","text":"Home Services Nanomedicines"},{"type":"h1","text":"Nanomedicines development and manufacturing"},{"type":"p","text":"We help you scale up to clinical schedules on time, guiding your nanomedicine candidate through its journey to the clinic and de-risk development with expertise encompassing scalable formulation, process and analytical development."},{"type":"h2","text":"Decomplicating Nanomedicines"},{"type":"p","text":"This fast-evolving field uses nanoscale or nanostructured materials to impart unique pharmacokinetic and therapeutic effects such as targeted delivery, enhanced efficacy and reduced toxicity."},{"type":"p","text":"Our team members have a unique scientific understanding of nanomedicines having advanced a range of formulations into the clinic. We bring this expertise to your project, using established methodologies and innovating when needed to give you the best possible outcomes."},{"type":"p","text":"De-complicating your projects with an integrated approach, our experts take ownership of the technology transfer of your existing process and the implementation of cGMP manufacturing as well as the synthesis of your lipids, polymers and other building blocks."},{"type":"p","text":"Synthesis of building blocks Nanoparticle expertise Process Development GMP Production Analytical Development CMC Regulatory"},{"type":"h2","text":"Synthesis of building blocks"},{"type":"p","text":"We support the development and manufacturing of building blocks necessary for the preparation of nanoparticles in addition to active pharmaceutical ingredients."},{"type":"p","text":"This includes:"},{"type":"p","text":"Custom lipids Monomers Polymers Inorganic complexes"},{"type":"h2","text":"Nanoparticle expertise"},{"type":"p","text":"We integrate analytical development for these APIs and building blocks alongside nanoparticle development to accelerate and de-risk your program."},{"type":"p","text":"We are experts in the following nanoparticles:"},{"type":"p","text":"Liposomes, lipid micelles and lipid nanoparticles Polymeric micelles and polymeric nanoparticles Iron oxide nanoparticles Silica nanoparticles Gold nanoparticles"},{"type":"p","text":" "},{"type":"h2","text":"Nanomedicine Process Development"},{"type":"p","text":"Our scientists develop phase-appropriate production processes in accordance with cGMP and mitigate technology transfer issues by using the same teams for development and manufacturing."},{"type":"p","text":"Techniques include:"},{"type":"p","text":"Flow manufacturing Batchwise synthesis Tangential flow filtration Magnetic separation Single-use purification systems Low bioburden and sterilizing filtrations"},{"type":"h2","text":"GMP Nanomedicine Production"},{"type":"p","text":"In our cGMP-compliant manufacturing facilities, we can produce volumes of a couple of milliliters to up to 300L in some instances, using batch-type and flow manufacturing processes."},{"type":"p","text":"We can handle highly potent drug substances in carefully engineered facilities and can deliver nanosuspensions and nanoparticle solutions as sterile finished drug products in vials or syringes."},{"type":"h2","text":"Analytical Development"},{"type":"p","text":"We are intimately familiar with defining the critical quality attributes (CQAs) of nanomedicines. To evaluate the CQAs of your GMP-produced drug products and to support product development, we utilize state-of-the-art analytical techniques."},{"type":"p","text":"We perform ICH-compliant stability testing of nanomedicines, APIs and novel excipients using stability indicating methods."},{"type":"h3","text":"Analytical techniques used"},{"type":"p","text":"Dynamic light scattering, Small-angle X-ray scattering Capillary electrophoresis Zeta-potential measurements Transmission and scanning electron microscopy Dynamic light scattering, small-angle X-ray scattering and laser diffraction Asymmetric flow field-flow fractionation – multi-angle light scattering (AF4-MALS) Size exclusion chromatography Zeta potential measurements Nuclear magnetic resonance, infrared and Raman spectroscopy HPLC/UPLC"},{"type":"h2","text":"Dossier Development and Strategic Regulatory Support"},{"type":"p","text":"Having advanced a wide range of nanomedicine formulations into the clinic, we are used to developing new manufacturing techniques and analytical procedures under fierce regulatory scrutiny."},{"type":"p","text":"Our dossier-oriented approach combined with deep understanding of the regulatory landscape gives your nanomedicine project the greatest chance of approval."},{"type":"h2","text":"Related Resources"},{"type":"p","text":"Our expert team members share their deep, scientific understanding and insights into nanomedicine development and manufacturing"},{"type":"h3","text":"On-demand webinar: Mastering Nanomedicines Characterization: Techniques for Determining Particle Size Distribution Based on Dynamic Light Scattering"},{"type":"h3","text":"Using Flow Technology in Nanoparticle Synthesis"},{"type":"h3","text":"Advancing oligonucleotide therapeutics with cutting-edge bioanalytics"},{"type":"h3","text":"Fit-for-Phase Nanomedicine Solutions"},{"type":"h3","text":"Deciphering the complex characteristics of nanoparticles by asymmetric flow field-flow fractionation"},{"type":"h3","text":"Navigating the CMC Regulatory Landscape for Oligonucleotide Therapeutics"},{"type":"h2","text":"Our integrated platforms"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your small molecule drug development."},{"type":"h3","text":"Drug substance"},{"type":"p","text":"Helping you turn your compounds that show promise into GMP-grade drug substances."},{"type":"p","text":"Process developmentAnalytical developmentSolid State ResearchAPI manufacturing"},{"type":"h3","text":"Drug product"},{"type":"p","text":"We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services."},{"type":"p","text":"FormulationAnalytical methodsGMP manufacturingClinical Supply"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline preparation and submission of your registration file."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your large molecule drug development."},{"type":"h3","text":"Drug product"},{"type":"p","text":"We advance your large molecule candidates through the pipeline quickly and safely with specialist drug product services."},{"type":"p","text":"FormulationAnalytical methodsAseptic manufacturingClinical Supply"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your large molecule drugs through preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your nanomedicine drug development."},{"type":"h3","text":"Drug product"},{"type":"p","text":"We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services."},{"type":"p","text":"Building block synthesisProcess developmentGMP productionAnalytical development"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"}],"loadingTime":0.6642704010009766,"lastModifiedAt":"2023-03-17T10:49:00.000Z","metaData":{"title":"Nanomedicines Development | Nanomedicines Manufacturing | Nanosuspension Formulation","description":"Ardena are a CDMO that provide nanomedicine development and manufacturing services guiding your nanomedicine candidate through its journey to the clinic.","tags":[],"image":null},"classification":{"label":"SERVICE","isVerified":true}}},{"score":3878.6746,"highlights":[{"location":"verifiedServicePage.h2","snippets":["Mastering Nanomedicines Characterization: Techniques for Determining Particle Size Distribution Based on Dynamic Light Scattering"]},{"location":"verifiedServicePage.metaTitle","snippets":["Nanomedicine Archives - Ardena"]}],"page":{"_id":"649d0165b94a31aeb664e641","url":{"entry":"https://ardena.com/service/nanomedicine/","target":"https://ardena.com/service/nanomedicine/"},"content":[{"type":"h2","text":"Mastering Nanomedicines Characterization: Techniques for Determining Particle Size Distribution Based on Dynamic Light Scattering"},{"type":"p","text":"The determination of particle size distribution (PSD) of drug nanocarriers is crucial for their successful development and use. Dynamic light scattering (DLS) is a commonly used technique for measuring PSD, and it provides information on the hydrodynamic size of particles by analyzing the fluctuations in scattering intensity over time. This webinar will cover the principles of DLS, including cumulants and regularization analysis, as well as the limitations of the technique, such as low resolution and accuracy for very polydisperse samples."},{"type":"p","text":"The webinar will also discuss multi-angle DLS, which can provide better resolution by measuring in forward, side, and backscattering angles, and spatially-resolved DLS, which is based on low coherence interferometry and can measure high concentrations of nanoparticles in flow or in containers. The application of DLS in the analysis of polystyrene size standards, mixtures of size standards, and drug products such as liposomes will be presented, along with the use of asymmetrical flow field-flow fractionation (AF4) in conjunction with DLS to measure PSD."},{"type":"p","text":"​​​​​​​Attendees of this webinar will gain a thorough understanding of the principles and techniques based on dynamic light scattering for determining the PSD of drug nanocarriers. They will learn about the advantages and limitations of these techniques, and gain insight into how to apply them to different types of drug nanocarriers. The webinar will provide attendees with valuable information and tools to help them optimize the development and use of nanomedicines in a variety of applications."},{"type":"h2","text":"Presenter"},{"type":"h3","text":"Maria Marioli, PhD"}],"loadingTime":0.5808651447296143,"lastModifiedAt":"2023-06-22T06:45:05.000Z","metaData":{"title":"Nanomedicine Archives - Ardena","description":"","tags":[],"image":null},"classification":{"label":"SERVICE","isVerified":true}}},{"score":3264.3325,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["We are also a leading nanomedicine developer."]},{"location":"descriptionPage.h3","snippets":["Fit-for-Phase Nanomedicine Solutions"]},{"location":"descriptionPage.metaTitle","snippets":["Ardena | Global CDMO | Leading Nanomedicine Developer"]}],"page":{"_id":"649d0168330eccda95148432","url":{"entry":"https://ardena.com/","target":"https://ardena.com/"},"content":[{"type":"h1","text":"Navigating you through drug development"},{"type":"p","text":"With deep scientific expertise, Ardena reliably guides you and your molecule through the challenging terrain of innovative drug development"},{"type":"p","text":"We walk the smartest path to your clinical milestones"},{"type":"p","text":"By seamlessly integrating our services, we’re able to better mitigate development risks and ultimately reduce time-to-clinic."},{"type":"p","text":"Our facilities are carefully engineered and uniquely built to support and enable early phase development for our partners' oral drugs, injectables and nanomedicines."},{"type":"h2","text":"Our integrated platforms"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your small molecule drug development."},{"type":"h3","text":"Drug substance"},{"type":"p","text":"Helping you turn your compounds that show promise into GMP-grade drug substances."},{"type":"p","text":"Process developmentAnalytical developmentSolid State ResearchAPI manufacturing"},{"type":"h3","text":"Drug product"},{"type":"p","text":"We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services."},{"type":"p","text":"FormulationAnalytical methodsGMP manufacturingClinical Supply"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline preparation and submission of your registration file."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your large molecule drug development."},{"type":"h3","text":"Drug product"},{"type":"p","text":"We advance your large molecule candidates through the pipeline quickly and safely with specialist drug product services."},{"type":"p","text":"FormulationAnalytical methodsAseptic manufacturingClinical Supply"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your large molecule drugs through preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h3","text":"Program management"},{"type":"p","text":"Using the right standards at the right development phase, our comprehensive program management services streamline your nanomedicine drug development."},{"type":"h3","text":"Drug product"},{"type":"p","text":"We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services."},{"type":"p","text":"Building block synthesisProcess developmentGMP productionAnalytical development"},{"type":"h3","text":"Bioanalysis"},{"type":"p","text":"Our bioanalytical platform supports your preclinical and clinical stages with expert testing services."},{"type":"p","text":"Mass spectrometryImmunochemistryFlow cytometryqPCR"},{"type":"h3","text":"CMC regulatory services"},{"type":"p","text":"Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines."},{"type":"p","text":"Scientific report writingModule 3 writingRegulatory CMC support"},{"type":"h2","text":"Resources"},{"type":"p","text":"Our team members share deep, scientific understanding and insights into their respective fields of expertise."},{"type":"h3","text":"On-demand webinar: Breaking the Bioavailability Barrier: Formulation strategies for Improving API Solubility"},{"type":"h3","text":"On-demand webinar: Mastering Nanomedicines Characterization: Techniques for Determining Particle Size Distribution Based on Dynamic Light Scattering"},{"type":"h3","text":"On-demand webinar: Preparative HPLC for Purification of Pharmaceutical Compounds: Methodologies and Case Studies"},{"type":"h3","text":"Exploring the Science and Technology Behind Fractionation, Purification, and Downstream Processing: From Discovery to Commercialization"},{"type":"h3","text":"On-demand webinar: Advancing Drug Development: Overcoming Bioanalytical Challenges of Nanomedicines and ADCs"},{"type":"h3","text":"On-demand webinar: Compatibility and In-Use Stability Studies for Injectables"},{"type":"h3","text":"Comparison of ELLA and Meso Scale Discovery V-Plex technologies for biomarker analysis"},{"type":"h3","text":"On-demand webinar: Navigating highly potent drugs to clinic: best practices from API to drug product"},{"type":"h3","text":"Using Flow Technology in Nanoparticle Synthesis"},{"type":"h3","text":"Advancing oligonucleotide therapeutics with cutting-edge bioanalytics"},{"type":"h3","text":"Phase-appropriate analytical method development"},{"type":"h3","text":"On-demand webinar: Capsules, a versatile OSD for early phase development"},{"type":"h3","text":"On-demand webinar: Navigating CMC requirements for Spray Drying Processes"},{"type":"h3","text":"On-demand webinar: From Molecule To Patient: Phase-Appropriate API Development Strategies"},{"type":"h3","text":"Scientific/CMC Writing and Regulatory Support"},{"type":"h3","text":"Fit-for-Phase Nanomedicine Solutions"},{"type":"h3","text":"Fill & Finish Services"},{"type":"h3","text":"Driving your lead candidate to clinic"},{"type":"h3","text":"Phase-appropriate drug substance manufacturing"},{"type":"h3","text":"Facilitating clinical trial success for drug products"},{"type":"h3","text":"Leading Bioanalytical Competencies"},{"type":"h3","text":"Excellence in solid state research"},{"type":"h3","text":"Drug substance for early clinical phase initiation – the underestimated risk of unexpected N‑nitrosamine impurities"},{"type":"h3","text":"Bioanalytical characterization and monitoring of ADCs supporting safety and efficacy from pre-clinical to clinical"},{"type":"h3","text":"Deciphering the complex characteristics of nanoparticles by asymmetric flow field-flow fractionation"},{"type":"h3","text":"Navigating the CMC Regulatory Landscape for Oligonucleotide Therapeutics"},{"type":"h3","text":"How to save significantly on early-phase clinical supply logistics?"},{"type":"h3","text":"How to enhance the safety of your drug substance synthesis process by smart chemical design?"},{"type":"h3","text":"Phase-appropriate development of a phase 1 oral dosage form"},{"type":"h3","text":"Strategies for Effective Cold Chain Packaging and Labelling"},{"type":"h3","text":"Timely Clinical Trial Material Services"},{"type":"h3","text":"Leverage the power of CMC in early drug development"},{"type":"h3","text":"Formulation and Process Considerations for Optimising Spray-Dried Solid Dispersions"},{"type":"h3","text":"Much more than just smoke - from marijuana to medicinal cannabis derived therapeutics"},{"type":"h3","text":"Development of an assay to predict immunogenicity for an analogue of an endogenous protein"},{"type":"h3","text":"Prevent undesired immunogenicity from becoming the barrier for innovative biotherapeutics"},{"type":"h3","text":"Scientific Advice and Dialogue with EMA during Drug Development"},{"type":"h3","text":"When to conduct a polymorph screening? Ardena’s phase-appropriate approach"},{"type":"h3","text":"What is an acceptable impurity level for a drug substance used in GLP toxicology studies?"},{"type":"h3","text":"Applying the science of advanced dissolution testing to accelerate product approval"},{"type":"h3","text":"Discriminatory dissolution test method in late development"},{"type":"h3","text":"Which solubility-enhancing technology should I use to support my early drug development project?"},{"type":"h3","text":"Powder blending in early-phase drug product development: Balancing art and science"},{"type":"h3","text":"Obtaining enantiopure drug substance through crystallization"},{"type":"h3","text":"Oligonucleotide therapeutics: How to measure plasma concentration, tissue distribution and immunogenicity?"},{"type":"h2","text":"Your molecule, your journey, our mission."},{"type":"p","text":"Get in touch to see how we can craft your path to the clinic with dedicated capabilities."}],"loadingTime":2.1690313816070557,"lastModifiedAt":"2023-02-28T12:03:52.000Z","metaData":{"title":"Ardena | Global CDMO | Leading Nanomedicine Developer","description":"Ardena are a global CDMO with an integrated & flexible full range of pharmaceutical services. We are also a leading nanomedicine developer.","tags":[],"image":null},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"64a6c67f17f3efdd62d9322f","name":"Cello Therapeutics","description":"This cell membrane coating technology is a recent breakthrough in the field of nanomedicine. Our target is to treat all types of cancers with a single delivery platform. In animal studies, the delivery of mRNA and siRNA via CNP platform increases efficiency over 10 times and 7 times, respectively. Founded in 2016 in San Diego, CA, Cello has been committed to saving patients’ lives. Our objective is to accelerate the process of delivering novel and effective medical treatments to cancer patients’ hands. Cello is a biomedical company in San Diego, California, founded in 2016. Cello develops biomimetic cell membrane-coated nanoparticles for cancer drug delivery, including chemotherapy agents, immunotherapy agents, or mRNA.","categories":["MANUFACTURER"],"employeeCountRange":"FROM_1_TO_10","foundingYear":2016,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/cello-therapeutics","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":"https://www.crunchbase.com/organization/cello-therapeutics","dnbUrl":null},"keywords":["nanotechnology","nanomedicine","nanoparticles","biopharmaceuticals","Therapeutics","oncology","Health Care","Biotechnology","polymer","biotechnology","Nanotechnology"],"websiteUrl":{"entry":"http://cellotherapeutics.com/","target":"https://cellotherapeutics.com/"},"logo":{"internalName":"ea99d8d9cfa0b52e12ba53114e708d_1645149031.jpg","name":"ea99d8d9cfa0b52e12ba53114e708d_1645149031.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a6c67f17f3efdd62d9322f"},"certifications":[],"location":{"_id":"64b66a1802a36268794b8796","city":"San Diego","state":"California","country":"United States","countryCode":"US"},"industries":[{"_id":"60dc4354637b44ca344b2cb4","name":"Science and Engineering"},{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"},{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"}]},"score":308.777,"pageHits":[{"score":3007.058,"highlights":[{"location":"descriptionPage.h3","snippets":["Cello produces breakthrough nanomedicines for cancer treatment"]},{"location":"descriptionPage.h1","snippets":["Cello produces breakthrough nanomedicines for cancer treatment"]}],"page":{"_id":"64a6c6f2b8d1d4d2a5785020","url":{"entry":"https://cellotherapeutics.com/","target":"https://cellotherapeutics.com/"},"content":[{"type":"h1","text":"“One in two men and one in three women will have cancer in their lifetime”"},{"type":"p","text":"-USA CDC"},{"type":"h1","text":"Cello is committed to saving lives"},{"type":"h1","text":"Cello produces breakthrough nanomedicines for cancer treatment"},{"type":"h1","text":"Cello's nanomedicines revolutionize chemotherapy and immunotherapy"},{"type":"h1","text":"“One in two men and one in three women will have cancer in their lifetime”"},{"type":"p","text":"-USA CDC"},{"type":"h1","text":"Cello is committed to saving lives"},{"type":"h1","text":"Cello produces breakthrough nanomedicines for cancer treatment"},{"type":"h1","text":"Cello's nanomedicines revolutionize chemotherapy and immunotherapy"},{"type":"h3","text":"“One in two men and one in three women will have cancer in their lifetime”"},{"type":"p","text":"-USA CDC"},{"type":"h3","text":"Cello is committed to saving lives"},{"type":"h3","text":"Cello produces breakthrough nanomedicines for cancer treatment"},{"type":"h3","text":"Cello's nanomedicines revolutionize chemotherapy and immunotherapy"},{"type":"h3","text":"Leading the way in cellular nanoparticle (CNP) delivery platforms for cancer treatment"},{"type":"p","text":"Cello is a biomedical company in San Diego, California, founded in 2016. Cello develops biomimetic cell membrane-coated nanoparticles for cancer drug delivery, including chemotherapy agents, immunotherapy agents, or mRNA. Our technology takes advantage of the properties of natural cellular membranes as a stealth coating for nanoparticles. Many animal studies indicated 85-100% of survival rate and long-term immunity for treating various solid tumors with the nanoparticles loaded with immunotherapy agent."}],"loadingTime":6.551659107208252,"lastModifiedAt":"2022-01-27T19:37:59.000Z","metaData":{"title":"Home - Cello Therapeutics - San Diego Biotech - Novel nanoparticle delivery platforms for cancer treatment","description":"Leading the way in nanoparticle delivery platforms for cancer treatment. Cello develops biomimetic cell membrane-coated nanoparticles for cancer drug delivery. Our technology takes advantage of the properties of natural cellular membranes as a stealth coating for nanoparticles.","tags":[],"image":{"internalName":"home1banner-cello-2.jpg","name":"home1banner-cello-2.jpg","url":"https://cellothera.wpengine.com/wp-content/uploads/2020/02/home1banner-cello-2.jpg"}},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"649dacc3970176ff14b8d816","name":"SomaServe","description":"SomaServe was spun out of UCL from the laboratories of Prof. Following a successful, oversubscribed late seed funding, the company now works from labs at the Babraham Research Campus. The company’s proprietary technology, PolyNaut® can be applied to both clinical and non clinical/ex vivo products. We work hard to deliver innovative science – but we have a lot of fun along the way. If that is the environment that you are looking for, then we would love to hear from you.","categories":["MANUFACTURER"],"employeeCountRange":"FROM_1_TO_10","foundingYear":2018,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/somaserve","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":"https://www.crunchbase.com/organization/somaserve","dnbUrl":null},"keywords":["Biotechnology"],"websiteUrl":{"entry":"http://somaserve.com/","target":"https://somaserve.com/"},"logo":{"internalName":"1a6186bdba6d6bbf2e4ee77405fc4e_1644600214.jpg","name":"1a6186bdba6d6bbf2e4ee77405fc4e_1644600214.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649dacc3970176ff14b8d816"},"certifications":[],"location":{"_id":"64b66a1802a36268794b87ca","city":"Cambridge","state":"England","country":"United Kingdom","countryCode":"GB"},"industries":[{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"}]},"score":272.02823,"pageHits":[{"score":5445.2285,"highlights":[{"location":"descriptionPage.h1","snippets":["Pioneering Nanomedicines for Crossing Biological Barriers"]},{"location":"descriptionPage.metaTitle","snippets":["Pioneering Nanomedicines for Crossing Biological Barriers > SomaServe"]}],"page":{"_id":"649dad0b2d3a825b8ab52288","url":{"entry":"https://somaserve.com/","target":"https://somaserve.com/"},"content":[{"type":"h1","text":"Pioneering Nanomedicines for Crossing Biological Barriers"},{"type":"h4","text":"From laboratories in Cambridge UK, SomaServe pioneers new medicines for crossing the blood brain barrier (BBB) and other biological barriers."},{"type":"h4","text":"In collaboration with partners, SomaServe is exploiting the proprietary technology, PolyNaut® — a versatile nano-engineered polymer technology for intracellular delivery."},{"type":"h2","text":"Polynaut® Collaborations"},{"type":"p","text":"SomaServe works with partners to develop new cutting edge therapeutic products that deliver cargoes to selected cells."},{"type":"p","text":"PolyNaut® technology can deliver a range of modalities including genetic materials (pDNA, mRNA and siRNA) and biologics – peptides and proteins including antibodies in CNS and non CNS indications."},{"type":"h2","text":"News & Events"},{"type":"h2","text":"SomaServe- successful closing of £2m late seed funding round"},{"type":"p","text":"SomaServe Ltd, a pioneer in nanomedicines for crossing biological barriers today announced that it has completed a highly successful, oversubscribed late seed funding of £2.1m.…"},{"type":"h2","text":"Abcam and SomaServe partnership"},{"type":"p","text":"Abcam and SomaServe announce comprehensive partnership to realise the potential of PolyNaut® ‘bionic’ nanoparticles for delivery to live cells.  Commercialise novel cell delivery platform technology Develop…"}],"loadingTime":0.7917356491088867,"lastModifiedAt":"2022-01-12T11:36:17.000Z","metaData":{"title":"Pioneering Nanomedicines for Crossing Biological Barriers > SomaServe","description":"","tags":[],"image":null},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"649c370dfe5141901d2c80ca","name":"Taiwan Liposome","description":"TLC is dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. TLC is dedicated to the research, development, and commercialization of best-in-class novel lipid nanoparticle (LNP)-based medicines.","categories":["MANUFACTURER"],"employeeCountRange":"FROM_101_TO_250","foundingYear":1997,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/tlcbio","facebookUrl":"https://www.facebook.com/tlcbiopharm/","twitterUrl":"https://www.twitter.com/tlcbio","crunchbaseUrl":"https://www.crunchbase.com/organization/the-liposome-company","dnbUrl":"https://www.dnb.com/business-directory/company-profiles.taiwan_liposome_co_ltd.1081d8d2b163d1ce2da3627ecc02e0f5.html"},"keywords":["Osteoarthritis","Ophthalmology","Drug Delivery","Medical and Diagnostic Laboratories","Professional, Scientific, and Technical Services","Pain Management","Biological laboratory","Drug Discovery","Oncology","Nanomedicine","Industry specialist consultants","Health Care","Biotechnology","Management, Scientific, and Technical Consulting Services","Drug Development","Medical"],"websiteUrl":{"entry":"http://www.tlcbio.com/","target":"https://www.tlcbio.com/"},"logo":{"internalName":"61d5f5992c676788ada6ae09_1642615865.jpg","name":"61d5f5992c676788ada6ae09_1642615865.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649c370dfe5141901d2c80ca"},"certifications":[],"location":{"_id":"64b66a1802a36268794b879e","city":"Taipei","state":null,"country":"Taiwan","countryCode":"TW"},"industries":[{"_id":"60dc4354637b44ca344b2cc1","name":"Professional Services"},{"_id":"60dc4354637b44ca344b2cb4","name":"Science and Engineering"},{"_id":"60dc4358637b44ca344b2cd5","name":"Biotechnology"},{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"}]},"score":263.8148,"pageHits":[{"score":8972.254,"highlights":[{"location":"verifiedProductPage.h1","snippets":["Antibody-Linked Nanomedicines"]}],"page":{"_id":"649c3753d987cefae88e1590","url":{"entry":"https://www.tlcbio.com/en-global/technology/index/targeted-delivery/active-targeting","target":"https://www.tlcbio.com/en-global/technology/index/targeted-delivery/active-targeting"},"content":[{"type":"h2","text":"Technology"},{"type":"h1","text":"Antibody-Linked Nanomedicines"},{"type":"p","text":"TLC is using antibodies and antibody fragments attached to lipid encapsulated drugs to develop more effective therapies in oncology. These antibody-linked nanomedicines actively target specific tissues using binding interactions between a specific antibody and a target antigen on the surface of a particular cell type. Compared with passively targeted therapies, these nanomedicines are better able to reach tissues farther from blood vessels and improve the biodistribution of the therapeutic payload. In addition, lipid-based antibody-linked nanomedicines can deliver a higher quantity of payload molecules compared to other actively targeted therapies like antibody-drug conjugates (ADCs). While ADC’s are capable of delivering 3 to 4 molecules of payload for each linked antibody, TLC’s nanomedicines are capable of delivering approximately 10,000 molecules with less than 100 antibodies. This approach is far more efficient and will likely translate into new treatments with higher efficacy. TLC’s development of antibody-linked nanomedicines builds on past successes in improving the delivery of cytotoxic drugs for therapies in oncology.  "},{"type":"p","text":"TLC is using antibodies and antibody fragments attached to lipid encapsulated drugs to develop more effective therapies in oncology. These antibody-linked nanomedicines actively target specific tissues using binding interactions between a specific antibody and a target antigen on the surface of a particular cell type. Compared with passively targeted therapies, these nanomedicines are better able to reach tissues farther from blood vessels and improve the biodistribution of the therapeutic payload. In addition, lipid-based antibody-linked nanomedicines can deliver a higher quantity of payload molecules compared to other actively targeted therapies like antibody-drug conjugates (ADCs). While ADC’s are capable of delivering 3 to 4 molecules of payload for each linked antibody, TLC’s nanomedicines are capable of delivering approximately 10,000 molecules with less than 100 antibodies. This approach is far more efficient and will likely translate into new treatments with higher efficacy. TLC’s development of antibody-linked nanomedicines builds on past successes in improving the delivery of cytotoxic drugs for therapies in oncology."},{"type":"p","text":"  Application Active targeting to disease site Advantages Active targeting Internalization of target liposome"},{"type":"p","text":"Application"},{"type":"p","text":"Active targeting to disease site"},{"type":"p","text":"Advantages"},{"type":"p","text":"Active targeting Internalization of target liposome"},{"type":"p","text":"Active targeting Internalization of target liposome"},{"type":"p","text":"About Company Overview Management Board of Directors Corporate Responsibility Pipeline Overview Pain Management Ophthalmology Oncology Infectious Diseases Technology Sustained Release Targeted Delivery Other Technologies Pressroom Press Releases Media Library Publications Careers Benefits Job Opportunities Contact Us"},{"type":"p","text":"Company Overview Management Board of Directors Corporate Responsibility"},{"type":"p","text":"Overview Pain Management Ophthalmology Oncology Infectious Diseases"},{"type":"p","text":"Sustained Release Targeted Delivery Other Technologies"},{"type":"p","text":"Press Releases Media Library Publications"},{"type":"p","text":"Benefits Job Opportunities"}],"loadingTime":5.901382207870483,"lastModifiedAt":null,"metaData":{"title":"Technology-TLC","description":"","tags":["Technology,TLC"],"image":null},"classification":{"label":"PRODUCT","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"649db414f01e4d8ba6625700","name":"Xerion Healthcare","description":"The company’s Oxilia nanoparticles have a physical mode of action and offer the ability to improve treatment of a wide range of solid tumours. Co-founded Oxonica, over 20 years experience in materials & nano-technology start-ups. Xerion is founded to bring Oxilia to market, based on patent filed in 2010. September - Innovate UK Biomedical Catalyst late stage grant awarded to support product scale-up & pre-clinical testing. One in two cancer patients receive radiotherapy – it is the primary treatment modality in 16% of cancer cures.","categories":["MANUFACTURER"],"employeeCountRange":"FROM_1_TO_10","foundingYear":2015,"digitalPresence":{"linkedinUrl":null,"facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":"https://www.crunchbase.com/organization/xerion-healthcare","dnbUrl":null},"keywords":["Health Care","Information Technology","Medical"],"websiteUrl":{"entry":"http://www.xerionhealthcare.co.uk/","target":"https://xerionhealthcare.co.uk/"},"logo":{"internalName":"0247fdc9928dc8f5bcf48be268d308_1644640352.jpg","name":"0247fdc9928dc8f5bcf48be268d308_1644640352.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/649db414f01e4d8ba6625700"},"certifications":[],"location":{"_id":"64b66a1a02a36268794b884f","city":"South Oxfordshire","state":"England","country":"United Kingdom","countryCode":"GB"},"industries":[{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"},{"_id":"60dc4354637b44ca344b2cb0","name":"Information Technology"}]},"score":244.29701,"pageHits":[{"score":3840.5657,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["Xerion is working to transform radiotherapy for cancer treatment using pioneering nanomedicine technology."]},{"location":"descriptionPage.h3","snippets":["Best-in-class nanomedicine"]},{"location":"descriptionPage.h1","snippets":["Xerion is working to transform radiotherapy for cancer treatment using pioneering nanomedicine technology"]}],"page":{"_id":"649db4447fad8aa662fba8f9","url":{"entry":"https://xerionhealthcare.co.uk/about/","target":"https://xerionhealthcare.co.uk/about/"},"content":[{"type":"p","text":"Home About Technology Product News Contact"},{"type":"h1","text":"ABOUT US"},{"type":"h1","text":"Xerion is working to transform radiotherapy for cancer treatment using pioneering nanomedicine technology"},{"type":"p","text":"Pioneering technology"},{"type":"p","text":"Xerion’s technology improves the effectiveness of conventional radiotherapy while minimising side-effects. The company’s Oxilia nanoparticles have a physical mode of action and offer the ability to improve treatment of a wide range of solid tumours."},{"type":"p","text":"A strong background, a strong future"},{"type":"p","text":"Spun out from Oxford University in 2015 following eight years of research, Xerion Healthcare is based and founded in the UK to develop and commercialise Oxilia treatment."},{"type":"h3","text":"Best-in-class nanomedicine"},{"type":"p","text":"Oxilia has a physical mode of action and Best-in-class radio sensitiser delivering unparalleled dose enhancement of radiotherapy Targeting a wide range of poorly treated solid tumours – initial focus on head & neck cancer Regulated as a class III medical device"},{"type":"h3","text":"Strong IP position"},{"type":"p","text":"Granted patents: EU, US, China, Japan Patent protection to 2037 Clear freedom-to-operate position Extensive manufacturing know-how"},{"type":"h2","text":"The Xerion Team"},{"type":"p","text":"Xerion’s management team has extensive commercial experience combined with pioneering nanotechnology expertise and support from world-leading oncologists."},{"type":"h3","text":"Prof Justin Stebbing, Chairman"},{"type":"p","text":"Professor of Cancer Medicine and Oncology, Consultant Oncologist, Imperial College"},{"type":"h3","text":"Ian George, NED"},{"type":"p","text":"Tech investor, extensive experience in developing & raising funds for healthcare companies"},{"type":"h3","text":"Gareth Wakefield, CEO"},{"type":"p","text":"Co-founded Oxonica, over 20 years experience in materials & nano-technology start-ups"},{"type":"h3","text":"Megan Adair, Quality and Operations Manager"},{"type":"p","text":"Over 10 years experience in quality assurance and quality control"},{"type":"h2","text":"Company Timeline"},{"type":"h2","text":"2015"},{"type":"p","text":"Xerion is founded to bring Oxilia to market, based on patent filed in 2010"},{"type":"p","text":"Xerion files patent to expand the scope of technology and its applications"},{"type":"p","text":"August 2015 - Seed investment from New Wave Ventures & Parkwalk Advisors"},{"type":"h2","text":"2017"},{"type":"p","text":"Innovate UK Biomedical Catalyst early stage grant awarded"},{"type":"p","text":"Xerion’s technology efficacy and safety demonstrated in vivo"},{"type":"p","text":"December 2017 - Investment from Oxford Sciences Innovation"},{"type":"h2","text":"2018"},{"type":"p","text":"Innovate UK Biomedical catalyst feasibility grant awarded"},{"type":"p","text":"April 2018 - Prof Justin Stebbing appointed to company Chair"},{"type":"h2","text":"2019"},{"type":"p","text":"September - Innovate UK Biomedical Catalyst late stage grant awarded to support product scale-up & pre-clinical testing"}],"loadingTime":3.8129231929779053,"lastModifiedAt":"2023-03-28T11:02:27.000Z","metaData":{"title":"About - Xerion Healthcare","description":"Xerion is working to transform radiotherapy for cancer treatment using pioneering nanomedicine technology.","tags":[],"image":{"internalName":"about-us-banner.jpg","name":"about-us-banner.jpg","url":"https://xerionhealthcare.co.uk/wp-content/uploads/2019/09/about-us-banner.jpg"}},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"64a0e9c24af5e4e4bd673369","name":"STANIPHARM","description":"StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services.","categories":["SERVICE_PROVIDER","MANUFACTURER"],"employeeCountRange":"FROM_11_TO_50","foundingYear":2010,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/stanipharm","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["drug delivery","supercritical fluids","formulation","nanoparticles","GMP manufacturing","poorly soluble drugs","sterilization","impregnation","purification","active pharmaceutical ingredients","CRO","CMO","crystallization","supercritical","poloxamer","prodrugs","polymer purification","medical cannabis","extraction","CDMO","Pharmaceuticals"],"websiteUrl":{"entry":"https://stanipharm.com/","target":"https://stanipharm.com/"},"logo":{"internalName":"f35c242c42038dc570d13304beebcf_1656328851.jpg","name":"f35c242c42038dc570d13304beebcf_1656328851.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64a0e9c24af5e4e4bd673369"},"certifications":[],"location":{"_id":"64b66d955cca02372672d56c","city":"Champigneulles","state":"Grand Est","country":"France","countryCode":"FR"},"industries":[{"_id":"60dc4354637b44ca344b2cba","name":"Health Care"}]},"score":236.33295,"pageHits":[{"score":5656.7246,"highlights":[{"location":"descriptionPage.h1","snippets":["Experts in supercritical fluids and nanomedicines"]},{"location":"descriptionPage.metaTitle","snippets":["StaniPharm | CDMO expert in supercritical fluids and nanomedicines"]}],"page":{"_id":"64a0e9f820c073dee6127b21","url":{"entry":"https://stanipharm.com/","target":"https://stanipharm.com/"},"content":[{"type":"h1","text":"Experts in supercritical fluids and nanomedicines"},{"type":"h2","text":"CDMO"},{"type":"p","text":"StaniPharm is a Contract Development and Manufacturing Organization (CDMO)."},{"type":"p","text":"Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services."},{"type":"h2","text":"Our tailored solutions to move your products from idea to market"},{"type":"h3","text":"Tailored drug (nano)particles"},{"type":"p","text":"We finely control the size and morphology of drug particles. We nanosize your Active Pharmaceutical Ingredients to tackle their poor aqueous solubility."},{"type":"h3","text":"Botanical extracts"},{"type":"p","text":"We solve extraction, purification and separation challenges to produce standardized broad spectrum extracts or isolate drug substances."},{"type":"h3","text":"Polymers and lipids"},{"type":"p","text":"We purify and fractionate challenging polymers and lipids for demanding medical and pharmaceutical applications."},{"type":"h3","text":"Nanoformulations"},{"type":"p","text":"We develop and scale-up the manufacturing of nano-enabled health products: nanoparticles, nanoemulsions..."},{"type":"h3","text":"StaniPharm was founded in 2010 but our history goes back much further than that."},{"type":"h3","text":"ANSM authorization to extract and formulate medical cannabis for research purposes"},{"type":"h4","text":"2021"},{"type":"h3","text":"GMP manufacturing of nanoparticles for vaccine formulation"},{"type":"h4","text":"2020"},{"type":"h3","text":"World's first aseptic supercritical fluid purification of an injectable polymer - Manufacturing of clinical trial materials (ISO 13485 and 13408)"},{"type":"h4","text":"2017"},{"type":"h3","text":"Design and qualification of an industrial unit for supercritical extraction of cannabis APIs"},{"type":"h4","text":"2015"},{"type":"h3","text":"Winner of the Deloitte In Extenso Technology Fast 50"},{"type":"h4","text":"2016"},{"type":"h3","text":"First clinical batch of drug nanocrystals using StaniTab® supercritical fluid technology"},{"type":"h4","text":"2014"},{"type":"h3","text":"With 40+ years of collective experience in supercritical fluids, our 3 founders spun off the Pharmaceutical Business Unit of SEPAREX"},{"type":"h4","text":"2010"},{"type":"h4","text":"Latest Blog Posts"},{"type":"h3","text":"Medical Cannabis: a crucial step towards a French ecosystem"},{"type":"h3","text":"A look back at some of 2021’s key highlights at StaniPharm"},{"type":"h3","text":"Vaxinano partners with StaniPharm for development and production of its vaccine delivery system"}],"loadingTime":5.481192588806152,"lastModifiedAt":"2021-12-10T10:06:12.000Z","metaData":{"title":"StaniPharm | CDMO expert in supercritical fluids and nanomedicines","description":"Pioneer CDMO in supercritical CO2 processes, we provide flexible development and GMP manufacturing services.","tags":[],"image":{"internalName":"Logo-agrandi-20-x-8-cm.jpg","name":"Logo-agrandi-20-x-8-cm.jpg","url":"https://stanipharm.com/wp-content/uploads/2020/11/Logo-agrandi-20-x-8-cm.jpg"}},"classification":{"label":"DESCRIPTION","isVerified":true}}}]},{"company":{"__typename":"CrawledCompanyOverview","_id":"64ac1f294e0874c0e5b22db3","name":"British Society for Nanomedicine","description":"We are honoured to be appointed as the Co-Chairs of the Board of Trustees of BSNM and would like to take this opportunity to thank Andrew Owen and Steve Rannard for all of their hard work, commitment and leadership over the last 10 years! We are delighted that Andrew and Steve will remain active in the Society moving forward. We are inviting BSNM members to become part of the BSNM Early Career Council (ECC). We are pleased to announce the British Society for Nanomedicine Annual Meeting 2024 will take place in Emmanuel College, University of Cambridge on the 9th & 10th September 2024. We are currently offering employers the chance to advertise their vacancies and studentships with us for free. As a registered charity (Charity number 1151497) our mission includes the direct explanation of the ongoing science and commercial developments to allow the public to understand and stay in touch with this exciting area as it impacts future global healthcare. The Society is affiliated to other leading organisations involved with nanomedicine including : CLINAM, the European Technology Platform for Nanomedicine, the British Pharmacological Society and the American Society for Nanomedicine. Maya Thanou is a professor of Pharmaceutical Nanotechnology at the Institute of Pharmaceutical Science, at the School of Cancer and Pharmaceutical Sciences, at King’s College London.","categories":[],"employeeCountRange":"FROM_11_TO_50","foundingYear":null,"digitalPresence":{"linkedinUrl":"https://www.linkedin.com/company/british-society-nanomedicine","facebookUrl":null,"twitterUrl":null,"crunchbaseUrl":null,"dnbUrl":null},"keywords":["nanomedicine","research","nanotechnology","science","innovation","collaboration"],"websiteUrl":{"entry":"http://britishsocietynanomedicine.org/","target":"https://www.britishsocietynanomedicine.org/"},"logo":{"internalName":"281eeeb3f7c1a5dd5bc4200543715b_1661077293.jpg","name":"281eeeb3f7c1a5dd5bc4200543715b_1661077293.jpg","url":"https://api.platform-production.ensun.io/file/external-company-logo/64ac1f294e0874c0e5b22db3"},"certifications":[],"location":{"_id":"64b66a1c02a36268794b892a","city":"Liverpool","state":"England","country":"United Kingdom","countryCode":"GB"},"industries":[{"_id":"60dc4354637b44ca344b2cb2","name":"Data and Analytics"}]},"score":223.44475,"pageHits":[{"score":5486.365,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["Welcome to the British Society for Nanomedicine With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK"]},{"location":"descriptionPage.h3","snippets":["Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."]},{"location":"descriptionPage.h2","snippets":["European Nanomedicine Meeting 2017"]},{"location":"descriptionPage.metaTitle","snippets":["The British Society for Nanomedicine – Created to raise awareness for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK"]}],"page":{"_id":"64ac1fbedec84e5cfbc40052","url":{"entry":"https://www.britishsocietynanomedicine.org/logout/","target":"https://www.britishsocietynanomedicine.org"},"content":[{"type":"p","text":"knowexplorelearn For researchers in the know! Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."},{"type":"h3","text":"knowexplorelearn For researchers in the know! Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."},{"type":"h3","text":"For researchers in the know!"},{"type":"p","text":"Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."},{"type":"h2","text":"Welcome to the British Society for Nanomedicine"},{"type":"h2","text":"Welcome to the British Society for Nanomedicine"},{"type":"p","text":"With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK"},{"type":"p","text":"_"},{"type":"p","text":"_"},{"type":"h2","text":"Nanomed Europe 2023"},{"type":"h3","text":"REGISTER NOW! 19th-22nd June"},{"type":"h4","text":"BSNM are proud to be part of the NanoMed Europe 2023 conference, for more information, please check out: http://www.nme23.eu/"},{"type":"p","text":"Registration and abstract submission now OPEN!"},{"type":"p","text":"_"},{"type":"p","text":"We are currently offering employers the chance to advertise their vacancies and studentships with us for free. Get in touch via britishsocietyfornanomedicine@gmail.com or simply fill in our quick and easy online form to upload your job advert to our website. We will promote any jobs to our membership through social media and occasionally through email."},{"type":"p","text":"Have a publication in the field of Nanomedicine? You can now Advertise your Nanomedicine Publications with us by simply filling in our simple Online Form."},{"type":"p","text":"The Celtic Advanced Life Sciences Innovation Network (CALIN) is a multi-partner Ireland-Wales project running until May 2023 that focuses on collaboration between academia and SMEs in Ireland and Wales in order to foster innovation in the life sciences sector, boost economic growth via the sector in the region and also improve patient wellbeing and healthcare."},{"type":"p","text":"Visit the website: www.calin.wales"},{"type":"p","text":"Find CALIN on Twitter @CALIN_LifeSci"},{"type":"p","text":"Or on Linked In https://www.linkedin.com/company/calin-life-science-ireland-wales"},{"type":"h2","text":"Latest News"},{"type":"h2","text":"Latest News"},{"type":"h2","text":"Professor’s New Role Helping to Promote Nanomedicine across the UK"},{"type":"p","text":"Swansea University Medical School’s Professor Steve Conlan has taken up a key role helping to highlight UK nanomedicine research. Swansea University Medical School’s Professor Steve Conlan has taken up a key role [...]"},{"type":"h2","text":"Nano-medicine shrinks the cost of HIV treatment (podcast)"},{"type":"p","text":"Nano-medicine shrinks the cost of HIV treatment (podcast) Professor Steve Rannard is a Professor of Chemistry at the University of Liverpool. Professor Andrew Owen is a Professor of Molecular and Clinical Pharmacology [...]"},{"type":"h2","text":"European Nanomedicine Meeting 2017"},{"type":"p","text":"European Nanomedicine Meeting 2017 To see some of the presentations from this year's European Nanomedicine Meeting in London click on the presenter's name below: Patrick Boisseau, ETPN, France Nathalie Mignet, [...]"},{"type":"p","text":"About Us BSNM Champions Member Publications Regulatory Authorities"},{"type":"p","text":"Previous Events Previous Presentations Upcoming Conferences NME 2023"},{"type":"p","text":"What is Nanomedicine Existing Nanomedicines Newsletter Nanomedicine Vacancies & Studentships FAQ’s"},{"type":"p","text":"STEM Activities Nano Movies Nano Podcasts Degree Programmes"}],"loadingTime":0.15723800659179688,"lastModifiedAt":null,"metaData":{"title":"The British Society for Nanomedicine – Created to raise awareness for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK","description":"Welcome to the British Society for Nanomedicine With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK","tags":[],"image":{"internalName":"nm-logo.svg","name":"nm-logo.svg","url":"https://www.britishsocietynanomedicine.org/wp-content/uploads/2017/09/nm-logo.svg"}},"classification":{"label":"DESCRIPTION","isVerified":true}}},{"score":5486.365,"highlights":[{"location":"descriptionPage.metaDescription","snippets":["Welcome to the British Society for Nanomedicine With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK"]},{"location":"descriptionPage.h3","snippets":["Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."]},{"location":"descriptionPage.h2","snippets":["European Nanomedicine Meeting 2017"]},{"location":"descriptionPage.metaTitle","snippets":["The British Society for Nanomedicine – Created to raise awareness for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK"]}],"page":{"_id":"64ac1fc67ccd51f1784a9953","url":{"entry":"https://www.britishsocietynanomedicine.org/members/","target":"https://www.britishsocietynanomedicine.org/"},"content":[{"type":"p","text":"knowexplorelearn For researchers in the know! Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."},{"type":"h3","text":"knowexplorelearn For researchers in the know! Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."},{"type":"h3","text":"For researchers in the know!"},{"type":"p","text":"Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research."},{"type":"h2","text":"Welcome to the British Society for Nanomedicine"},{"type":"h2","text":"Welcome to the British Society for Nanomedicine"},{"type":"p","text":"With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK"},{"type":"p","text":"_"},{"type":"p","text":"_"},{"type":"h2","text":"Nanomed Europe 2023"},{"type":"h3","text":"REGISTER NOW! 19th-22nd June"},{"type":"h4","text":"BSNM are proud to be part of the NanoMed Europe 2023 conference, for more information, please check out: http://www.nme23.eu/"},{"type":"p","text":"Registration and abstract submission now OPEN!"},{"type":"p","text":"_"},{"type":"p","text":"We are currently offering employers the chance to advertise their vacancies and studentships with us for free. Get in touch via britishsocietyfornanomedicine@gmail.com or simply fill in our quick and easy online form to upload your job advert to our website. We will promote any jobs to our membership through social media and occasionally through email."},{"type":"p","text":"Have a publication in the field of Nanomedicine? You can now Advertise your Nanomedicine Publications with us by simply filling in our simple Online Form."},{"type":"p","text":"The Celtic Advanced Life Sciences Innovation Network (CALIN) is a multi-partner Ireland-Wales project running until May 2023 that focuses on collaboration between academia and SMEs in Ireland and Wales in order to foster innovation in the life sciences sector, boost economic growth via the sector in the region and also improve patient wellbeing and healthcare."},{"type":"p","text":"Visit the website: www.calin.wales"},{"type":"p","text":"Find CALIN on Twitter @CALIN_LifeSci"},{"type":"p","text":"Or on Linked In https://www.linkedin.com/company/calin-life-science-ireland-wales"},{"type":"h2","text":"Latest News"},{"type":"h2","text":"Latest News"},{"type":"h2","text":"Professor’s New Role Helping to Promote Nanomedicine across the UK"},{"type":"p","text":"Swansea University Medical School’s Professor Steve Conlan has taken up a key role helping to highlight UK nanomedicine research. Swansea University Medical School’s Professor Steve Conlan has taken up a key role [...]"},{"type":"h2","text":"Nano-medicine shrinks the cost of HIV treatment (podcast)"},{"type":"p","text":"Nano-medicine shrinks the cost of HIV treatment (podcast) Professor Steve Rannard is a Professor of Chemistry at the University of Liverpool. Professor Andrew Owen is a Professor of Molecular and Clinical Pharmacology [...]"},{"type":"h2","text":"European Nanomedicine Meeting 2017"},{"type":"p","text":"European Nanomedicine Meeting 2017 To see some of the presentations from this year's European Nanomedicine Meeting in London click on the presenter's name below: Patrick Boisseau, ETPN, France Nathalie Mignet, [...]"},{"type":"p","text":"About Us BSNM Champions Member Publications Regulatory Authorities"},{"type":"p","text":"Previous Events Previous Presentations Upcoming Conferences NME 2023"},{"type":"p","text":"What is Nanomedicine Existing Nanomedicines Newsletter Nanomedicine Vacancies & Studentships FAQ’s"},{"type":"p","text":"STEM Activities Nano Movies Nano Podcasts Degree Programmes"}],"loadingTime":0.2032792568206787,"lastModifiedAt":null,"metaData":{"title":"The British Society for Nanomedicine – Created to raise awareness for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK","description":"Welcome to the British Society for Nanomedicine With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK","tags":[],"image":{"internalName":"nm-logo.svg","name":"nm-logo.svg","url":"https://www.britishsocietynanomedicine.org/wp-content/uploads/2017/09/nm-logo.svg"}},"classification":{"label":"DESCRIPTION","isVerified":true}}},{"score":1963.0635,"highlights":[{"location":"verifiedServicePage.metaTitle","snippets":["Services – The British Society for Nanomedicine"]}],"page":{"_id":"64ac1fb7de139b4cd5f989f2","url":{"entry":"https://www.britishsocietynanomedicine.org/services/","target":"https://www.britishsocietynanomedicine.org/services/"},"content":[{"type":"h1","text":"Services"},{"type":"h2","text":"Research"},{"type":"p","text":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent ac nibh vestibulum, laoreet ipsum quis, vestibulum nisi. Curabitur non mi et turpis pharetra vulputate."},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor Results Orientated – Sed consequat odio quis dictum Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor"},{"type":"p","text":"Results Orientated – Sed consequat odio quis dictum"},{"type":"p","text":"Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo urna urna in elit. Nunc vulputate tincidunt risus non."},{"type":"h2","text":"Discovery"},{"type":"p","text":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent ac nibh vestibulum, laoreet ipsum quis, vestibulum nisi. Curabitur non mi et turpis pharetra vulputate."},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor Results Orientated – Sed consequat odio quis dictum Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor"},{"type":"p","text":"Results Orientated – Sed consequat odio quis dictum"},{"type":"p","text":"Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo urna urna in elit. Nunc vulputate tincidunt risus non."},{"type":"h2","text":"Analysis"},{"type":"p","text":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent ac nibh vestibulum, laoreet ipsum quis, vestibulum nisi. Curabitur non mi et turpis pharetra vulputate."},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor Results Orientated – Sed consequat odio quis dictum Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor"},{"type":"p","text":"Results Orientated – Sed consequat odio quis dictum"},{"type":"p","text":"Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo urna urna in elit. Nunc vulputate tincidunt risus non."},{"type":"h2","text":"Testing"},{"type":"p","text":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent ac nibh vestibulum, laoreet ipsum quis, vestibulum nisi. Curabitur non mi et turpis pharetra vulputate."},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor Results Orientated – Sed consequat odio quis dictum Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Data Driven – cras volutpat odio ac sapien faucibus auctor"},{"type":"p","text":"Results Orientated – Sed consequat odio quis dictum"},{"type":"p","text":"Research Led – Nam ac pharetra nibh. Nullam eu magna sit"},{"type":"p","text":"Ut convallis, magna sed dapibus tincidunt, nulla lacus sollicitudin nisi, id commodo urna urna in elit. Nunc vulputate tincidunt risus non."},{"type":"h2","text":"Discover The Future"},{"type":"p","text":"We are a multi-disciplinary laboratory committed to focussed and efficient drug discovery"}],"loadingTime":0.7279675006866455,"lastModifiedAt":null,"metaData":{"title":"Services – The British Society for Nanomedicine","description":"Research \r\n\r\nLorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent ac nibh vestibulum, laoreet ipsum quis, vestibulum nisi. Curabitur non mi et turpis pharetra vulputate. \r\n\r\nData Driven - cras volutpat odio ac sapien faucibus auctor \r\n\r\nResults Orientated – Sed consequat odio quis dictum \r\n\r\nResearch Led – Nam ac pharetra nibh. Nullam eu magna sit","tags":[],"image":{"internalName":"nm-logo.svg","name":"nm-logo.svg","url":"https://www.britishsocietynanomedicine.org/wp-content/uploads/2017/09/nm-logo.svg"}},"classification":{"label":"SERVICE","isVerified":true}}}]}],"highlightPhrase":"Nanomedicine"}],["$","$L1b",null,{"query":"Nanomedicine","resultCount":56}],["$","$L1c",null,{"title":"Nanomedicine","description":"Nanomedicine is a branch of medical science that utilizes nanotechnology to diagnose and treat medical conditions. It seeks to exploit the unique properties of nanoscale materials to create new medical treatments, diagnostic tools, and delivery systems for medicines and therapeutic agents. Nanomedicine is a fast-developing field, with the potential to revolutionize the way medical treatments are delivered to patients."}],["$","$L1d",null,{"data":[{"query":"Nano-Medicine","slug":"nano-medicine"},{"query":"Nanoparticle","slug":"nanoparticle"},{"query":"Nanomaterial","slug":"nanomaterial"},{"query":"Nanomagnetism","slug":"nanomagnetism"}]}]] 2:[[["$","meta",null,{"charSet":"utf-8"}],["$","title",null,{"children":"Top Nanomedicine companies and suppliers | ensun"}],["$","meta",null,{"name":"description","content":"Discover 56 Nanomedicine companies, suppliers and manufacturers. Worldwide results. Direct access without registration"}],null,null,null,null,null,null,null,null,["$","meta",null,{"name":"viewport","content":"width=device-width, initial-scale=1, maximum-scale=1"}],null,null,null,null,null,null,null,null,null,null,[]],[["$","link",null,{"rel":"canonical","href":"https://ensun.io/search/nanomedicine"}],null,null,null],null,null,[null,null,null,null,null],null,[null,["$","meta",null,{"property":"og:title","content":"Top Nanomedicine companies and suppliers | ensun"}],["$","meta",null,{"property":"og:description","content":"Discover 56 Nanomedicine companies, suppliers and manufacturers. Worldwide results. Direct access without registration"}],["$","meta",null,{"property":"og:url","content":"https://ensun.io/search/nanomedicine"}],["$","meta",null,{"property":"og:site_name","content":"ensun"}],["$","meta",null,{"property":"og:locale","content":"en"}],null,null,null,null,null,null,null,null,null,["$","meta",null,{"property":"og:type","content":"website"}]],null,null,[null,[["$","link",null,{"rel":"icon","href":"/favicon.ico","type":"image/x-icon","sizes":"any"}]],[],null]]